NF1 Gene

Aliases
for NF1 gene

Previous GC identifers: GC17M029610 GC17P031329 GC17P029271 GC17P029567 GC17P026446 GC17P025632

Summaries
for NF1 gene

Genomic Views
for NF1 gene

RefSeq DNA sequence:

NC_000017.10  NC_018928.1  NT_010799.15  

SwitchGear Promoter luciferase reporter plasmids (see all 2): NF1 promoter sequence

QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat NF1

NF1 Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)


GeneLoc information about chromosome 17         GeneLoc Exon Structure

GeneLoc location for GC17P029421:  view genomic region     (about GC identifiers)

Proteins
for NF1 gene

6 PDB 3D structures from and Proteopedia for NF1:

1NF1 (3D)        2D4Q (3D)        2E2X (3D)        3P7Z (3D)        3PEG (3D)        3PG7 (3D)    

Explore the universe of human proteins at neXtProt for NF1: NX_P21359

Post-translational modifications:

	Browse Purified and Recombinant Proteins at EMD Millipore
	Browse R&D Systems for human recombinant proteins
	Browse recombinant and purified proteins available from Enzo Life Sciences
	Browse OriGene full length recombinant human proteins expressed in human HEK293 cells OriGene Protein Over-expression Lysate: NF1 OriGene Custom Protein Services for NF1
	GenScript Custom Purified and Recombinant Proteins Services for NF1
	Novus Biologicals NF1 Protein
	Browse Sino Biological Recombinant Proteins
	Browse ProSpec Recombinant Proteins
	Uscn Proteins for NF1

Gene Ontology (GO): 5/6 cellular component terms (GO ID links to tree view) (see all 6):    About this table

	EMD Millipore Mono- and Polyclonal Antibodies for the study of NF1
	Browse R&D Systems for Antibodies
	OriGene Antibodies: NF1 OriGene Custom Antibody Services for NF1
	GenScript Superior Antibodies for NF1
	Novus Biologicals NF1 Antibodies
	Search for Antibodies for NF1 at Abcam
	Uscn Antibodies for NF1
	ThermoFisher Antibody for NF1

	Browse Kits and Assays available from EMD Millipore
	OriGene Custom Immunoassay Development Browse OriGene Fluorogenic Cell Assay Kits
	Browse R&D Systems for biochemical assays
	GenScript Custom Assay Services for NF1
	Browse Enzo Life Sciences for kits & assays
	Uscn ELISAs and CLIAs for NF1

Protein Domains /
Families
for NF1 gene

ProtoNet protein and cluster: P21359

Function
for NF1 gene

miRNA Products:		miRTarBase miRNAs that target NF1: hsa-mir-10b (MIRT005504)
		OriGene 3'-UTR Clone (see all 3): NF1 Browse MicroRNA Expression Plasmids
		QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat NF1
		8/100 QIAGEN miScript miRNA Assays for microRNAs that regulate NF1 (see all 100):
		hsa-miR-411* hsa-miR-323-3p hsa-miR-3607-3p hsa-miR-15a hsa-miR-128 hsa-miR-3074-3p hsa-miR-30d hsa-miR-519a
		SwitchGear 3'UTR luciferase reporter plasmid: NF1 3' UTR sequence

Inhib. RNA Products:		Browse for Gene Knock-down Tools from EMD Millipore
		OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for NF1 (see all 7) OriGene shRNA RFP: NF1 OriGene siRNA: NF1
		QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat NF1

Gene Editing Products:

DNA2.0 Custom Protein Engineering Service for NF1

Clone Products:		Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
		OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for NF1 (see all 5) OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for NF1 (see all 3) OriGene custom cloning services – gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
		GenScript: all cDNA clones in your preferred vector: NF1 (NM_002236)
		Browse Sino Biological Human cDNA Clones
		DNA2.0 Custom Codon Optimized Gene Synthesis Service for NF1
		Search Vector BioLabs for ready-to-use adenovirus/AAV for human, mouse, rat NF1

Cell Line Products:		GenScript Custom overexpressing Cell Line Services for NF1
		Search LifeMap BioReagents cell lines for NF1

In Situ Assay Products:

Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for NF1

Gene Ontology (GO): 3 molecular function terms (GO ID links to tree view):    About this table

15/23 MGI mutant phenotypes (inferred from 7 alleles) (MGI details for Nf1)

Pathways & Interactions
for NF1 gene

	Super-pathway	contained gene-specific pathways
1	G-protein signaling TC21 regulation pathway	G-protein signaling TC21 regulation pathway 1.00 G-protein signaling_M-RAS regulation pathway 0.71 G-protein signaling_TC21 regulation pathway 1.00 G-protein signaling M-RAS regulation pathway 0.71
2	Development VEGF signaling via VEGFR2 - generic cascades	Development VEGF signaling via VEGFR2 - generic cascades 1.00 Development_VEGF signaling and activation 0.75 Development VEGF signaling and activation 0.75 Development_VEGF signaling via VEGFR2 - generic cascades 0.51
3	MAPK signaling pathway	MAPK signaling pathway 1.00 MAPK signaling pathway 0.50
4	pilocytic astrocytoma	pilocytic astrocytoma 1.00
5	Integrated Breast Cancer Pathway	Integrated Breast Cancer Pathway 1.00

4 EMD Millipore Pathways for NF1

	Development VEGF signaling and activation
	G-protein signaling M-RAS regulation pathway
	G-protein signaling TC21 regulation pathway
	Development VEGF signaling via VEGFR2 - generic cascades

2 Downloadable PowerPoint Slides of QIAGEN Pathway Central Maps for NF1

	Molecular Mechanisms of Cancer
	Glioblastoma Multiforme

4 GeneGo (Thomson Reuters) Pathways for NF1

	G-protein signaling TC21 regulation pathway
	G-protein signaling M-RAS regulation pathway
	Development VEGF signaling via VEGFR2 - generic cascades
	Development VEGF signaling and activation

5/7 BioSystems Pathways for NF1

	Integrated Breast Cancer Pathway
	MAPK signaling pathway
	Signaling Pathways in Glioblastoma
	pilocytic astrocytoma
	Syndecan-2-mediated signaling events

1         Kegg Pathway  (Kegg details for NF1)

MAPK signaling pathway

Gene Ontology (GO): 5/64 biological process terms (GO ID links to tree view) (see all 64):    About this table

Drugs & Compounds
for NF1 gene

Transcripts
for NF1 gene

Expression
for NF1 gene

NF1 expression in normal human tissues (normalized intensities)
See probesets specificity/sensitivity at GeneAnnot
About this imageBioGPS
CGAP TAG: --

1 LifeMap In Vivo Development Anatomical Compartment/Cell
	Tissue Anatomical Compartment Cell			Category (developmental path)
	HeartAtrioventricular ValvesAtrioventricular Valve Cells			Endocardium, Myocardium
Expression: Positive    Negative     Selective marker Experimental details: Curated     Microarrays     In-situ hybridization

Primer Products:		OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for NF1 Browse OriGene validated miRNA SYBR primer pairs
		SABiosciences RT2 qPCR Primer Assay in human, mouse, rat NF1
		QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat NF1
		QIAGEN QuantiFast Probe-based Assays in human, mouse, rat NF1

In Situ Assay Products:

Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for NF1

Orthologs
for NF1 gene

Paralogs
for NF1 gene

Paralogs for NF1 gene

2 SIMAP similar genes for NF1 using alignment to 17 protein entries:     NF1_HUMAN (see all proteins):

DKFZp686J1293    NF1 gene homologue

NF1 for paralogs           About GeneDecksing


5/9 Pseudogenes.org Pseudogenes for NF1 (see all 9)
PGOHUM00000239411 PGOHUM00000247700 PGOHUM00000258760 PGOHUM00000246630 PGOHUM00000246642

Genomic Variants
for NF1 gene

10/4086 NCBI SNPs in NF1 are shown (see all 4086)     About this table

Genomic Data					Transcription Related Data				Allele Frequencies
SNP ID	Valid	Clinical significance	Chr 17 pos	Sequence	#	AA Chg	Type	More	#	Allele freq	Pop	Total sample	More
-1st2nd3rd	-1st2nd3rd	-1st2nd3rd	-1st2nd3rd	--	--	--	-1st2nd3rd	--	--	-1st2nd3rd	-1st2nd3rd	-1st2nd3rd
rs1994747921,2	C	pathogenic	27340508(+)	ATGGCC/TGTCAA	4	P L	mis1		0	--	--	--	--
rs1378545561,2	C	pathogenic	27439384(+)	CTTCCA/C/GAGGCA	6	Q P R	mis1		0	--	--	--	--
rs1378545661,2	C	pathogenic	27445967(+)	CTTCCC/G/TTTGTG	6	P R L	mis1		0	--	--	--	--
rs1994747321,2	C	untested	27441998(+)	CTGATC/G/TGGTTT	6	R G W	mis1		0	--	--	--	--
rs1994747401,2	C,	untested	27443021(+)	CAAGCA/GTGGAA	4	M V	mis1		0	--	--	--	--
rs1427127511,2	C,F,	untested	27451579(+)	AAATAC/G/TTGATC	6	L V	syn1 mis1		2		NA EU	5397
rs178793861,2	C,F,	--	25630938(+)	ACATAG/ACAAGA	3	--	us2k1		3		NS NA	302
rs96752071,2	C,F,	--	25631104(+)	actgcA/Gcagag	3	--	us2k1		3		WA	122
rs1116379661,2		--	25631152(+)	GGTAAA/TATGTA	3	--	us2k1		2		CSA WA	120
rs178857171,2	C,	--	25631541(+)	TGGATG/ATAATC	3	--	us2k1		1		NS	150

HapMap Linkage Disequilibrium report for NF1 (29421945 - 29671945 bp, first 250kb of NF1)
Structural Variations (Copy Number Variations, Insertions/Deletions, Inversions)
Database of Genomic Variants (DGV): 8 variations for NF1
     4 CNVs: 72861 4999 72862 72860
     4 Indels: 40176 42474 61566 34310
Human Gene Mutation Database (HGMD): NF1

Locus Specific Mutation Databases (LSDB): NF1

5/15 SABiosciences Cancer Mutation PCR Assays for NF1 (see all 15): Cosmic Id AA Change 24576 p.K1444E 24444 p.R816* 24443 p.R1362* 24486 p.R304* 24495 p.Q514fs*43

1 SABiosciences Cancer Mutation PCR Array containing NF1: Tumor Suppressor Panel 384HT

1 SABiosciences qBiomarker Copy Number PCR Array containing NF1: Oncogenes & Tumor Suppressor Genes 384HC

QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing NF1

DNA2.0 Custom Variant and Variant Library Synthesis for NF1

Disorders / Diseases
for NF1 gene

20/110 diseases for NF1

10/92 Novoseek disease relationships for NF1 gene (see all 92)    About this table

Publications
for NF1 gene

PubMed articles for NF1 gene, integrated from 9 sources (see all 745) (see top 10): (articles sorted by number of sources associating them with NF1)

Utopia: connect your pdf to the dynamic world of online information

1. NF1 gene analysis based on DHPLC. (PubMed id 12552569)^{1, 2, 4, 9} De Luca A.... Dallapiccola B. (2003)
2. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. (PubMed id 16380919)^{1, 2, 4} De Luca A.... Dallapiccola B. (2005)
3. Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1. (PubMed id 15146469)^{1, 2, 4} De Luca A.... Dallapiccola B. (2004)
4. Exon 10b of the NF1 gene represents a mutational hotspot and harbors a recurrent missense mutation Y489C associated with aberrant splicing. (PubMed id 11258625)^{1, 2, 4} Messiaen L.M.... Wallace M.R. (1999)
5. Genomic organization of the neurofibromatosis 1 gene (NF1). (PubMed id 7774960)^{1, 2, 9} Li Y.... Viskochil D. (1995)
6. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases. (PubMed id 13679444)^{1, 4, 9} Lasota J....Miettinen M. (2003)
7. Evidence for the presence of two amino-terminal isoforms of neurofibromin, a gene product responsible for neurofibromatosis type 1. (PubMed id 7570581)^{1, 2, 9} Suzuki H.... Shibahara S. (1995)
8. Somatic mutations in the neurofibromatosis 1 gene in human tumors. (PubMed id 1568247)^{1, 2, 9} Li Y.... Cawthon R.M. (1992)
9. NF1 mutations and clinical spectrum in patients with spinal neurofibromas. (PubMed id 12746402)^{1, 2, 9} Kluwe L.... Mautner V.F. (2003)
10. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1 (NF1). (PubMed id 9668168)^{1, 2, 9} Klose A....Nuernberg P. (1998)
11. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. (PubMed id 2121371)^{1, 2, 9} Ballester R.... Collins F.S. (1990)
12. Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas. (PubMed id 22108604)^{1, 2} Thomas L.... Upadhyaya M. (2012)
13. Noonan syndrome and neurofibromatosis type I in a fam ily with a novel mutation in NF1. (PubMed id 19845691)^{1, 2} NystrAPm A.M....AnnerAcn G. (2009)
14. Neurofibromatous neuropathy in neurofibromatosis 1 (NF1). (PubMed id 15520408)^{1, 2} Ferner R.E.... Johnson M.R. (2004)
15. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1. (PubMed id 15523642)^{1, 2} Zatkova A.... Wimmer K. (2004)
16. Functional analysis of polymorphic variation within the promoter and 5' untranslated region of the neurofibromatosis type 1 (NF1) gene. (PubMed id 15523626)^{1, 4} Horan M.P....Upadhyaya M. (2004)
17. Association between the neurofibromatosis-1 (NF1) locus and autism in the Japanese population. (PubMed id 15389774)^{1, 4} Marui T....Sasaki T. (2004)
18. Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene. (PubMed id 14722914)^{1, 4} Kluwe L....Mautner V.F. (2004)
19. Different mutations in the NF1 gene are associated with neurofibromatosis-Noonan syndrome (NFNS). (PubMed id 12707950)^{1, 2} Baralle D.... ffrench-Constant C. (2003)
20. Status of the NF1 tumor suppressor locus in uveal melanoma. (PubMed id 12963615)^{1, 4} Foster W.J....Harbour J.W. (2003)
21. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. (PubMed id 12522551)^{1, 2} Wang Q.... Puisieux A. (2003)
22. NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas. (PubMed id 11857752)^{1, 2} Kluwe L.... Mautner V.-F. (2002)
23. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme. (PubMed id 11727199)^{1, 2} Mukhopadhyay D....Davidson N.O. (2002)
24. Spinal neurofibromatosis without cafe-au-lait macules in two families with null mutations of the NF1 gene. (PubMed id 11704931)^{1, 2} Kaufmann D.... Assum G. (2001)
25. Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 ( NF1) gene. (PubMed id 11735023)^{1, 2} Han S.S.... Upadhyaya M.N. (2001)
26. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. (PubMed id 10607834)^{1, 2} Ars E....Estivill X. (2000)
27. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. (PubMed id 10712197)^{1, 2} Fahsold R.... Nuernberg P. (2000)
28. A novel mutation L1425P in the GAP-region of the NF1 gene detected by temperature gradient gel electrophoresis (TGGE). (PubMed id 10220149)^{1, 2} Peters H.... Schuelke M. (1999)
29. Analysis of CpG C-to-T mutations in neurofibromatosis type 1. (PubMed id 10336779)^{1, 2} Krkljus S.... Wallace M.R. (1998)
30. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. (PubMed id 9003501)^{1, 2} Upadhyaya M....Cooper D.N. (1997)
31. Six novel mutations in the neurofibromatosis type 1 (NF1) gene. (PubMed id 9298829)^{1, 2} Upadhyaya M.... Harper P.S. (1997)
32. Novel and recurrent mutations in the neurofibromatosis type 1 (NF1) gene. (PubMed id 9101300)^{1, 2} Hudson J.... Thakker N. (1997)
33. Emergence and scattering of multiple neurofibromatosis (NF1)-related sequences during hominoid evolution suggest a process of pericentromeric interchromosomal transposition. (PubMed id 9002664)^{1, 2} Regnier V.... Danglot G. (1997)
34. Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene. (PubMed id 9150739)^{1, 2} Maynard J.... Upadhyaya M. (1997)
35. Molecular genetics of neurofibromatosis type 1 (NF1). (PubMed id 8825042)^{1, 2} Shen M.H.... Upadhyaya M. (1996)
36. The neurofibromatosis type I messenger RNA undergoes base- modification RNA editing. (PubMed id 8602361)^{1, 2} Skuse G.R.... Smith H.C. (1996)
37. Scanning the first part of the neurofibromatosis type 1 gene by RNA- SSCP: identification of three novel mutations and of two new polymorphisms. (PubMed id 8834249)^{1, 2} Gasparini P.... Zelante L. (1996)
38. Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome. (PubMed id 8807336)^{1, 2} Wu R....Fryns J.-P. (1996)
39. Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene. (PubMed id 8544190)^{1, 2} Upadhyaya M.... Harper P.S. (1995)
40. Characterisation of inherited and sporadic mutations in neurofibromatosis type-1. (PubMed id 7981679)^{1, 2} Purandare S.M.... Connor J.M. (1994)
41. Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene. (PubMed id 7981724)^{1, 2} Upadhyaya M.... Harper P.S. (1994)
42. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene. (PubMed id 8081387)^{1, 2} Abernathy C.R.... Wallace M.R. (1994)
43. Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome. (PubMed id 8317503)^{1, 2} Tassabehji M.... Thakker N. (1993)
44. Neurofibromatosis type 1 (NF1): the search for mutations by PCR- heteroduplex analysis on Hydrolink gels. (PubMed id 7904209)^{1, 2} Shen M.H.... Upadhyaya M. (1993)
45. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. (PubMed id 8417346)^{1, 2} Andersen L.B.... Collins F.S. (1993)
46. Molecular cloning of a cDNA coding for neurofibromatosis type 1 protein isoform lacking the domain related to ras GTPase-activating protein. (PubMed id 1339276)^{1, 2} Suzuki H.... Shibahara S. (1992)
47. Analysis of mutations at the neurofibromatosis 1 (NF1) locus. (PubMed id 1302608)^{1, 2} Upadhyaya M.... Harper P.S. (1992)
48. Complete human NF1 cDNA sequence: two alternatively spliced mRNAs and absence of expression in a neuroblastoma line. (PubMed id 1457041)^{1, 2} Bernards A....Gusella J.F. (1992)
49. The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin. (PubMed id 1715669)^{1, 3} Skuse G.R....Rowley P.T. (1991)
50. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. (PubMed id 1783401)^{1, 2} Marchuk D.A....Collins F.S. (1991)
51. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. (PubMed id 1923522)^{1, 2} Nishi T.... Saya H. (1991)
52. Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain. (PubMed id 1662505)^{1, 2} Suzuki Y.... Shibahara S. (1991)
53. Type 1 neurofibromatosis gene: correction. (PubMed id 2125369)^{1, 2} (1990)
54. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. (PubMed id 2114220)^{1, 2} Cawthon R.M.... White R. (1990)
55. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. (PubMed id 2134734)^{1, 2} Wallace M.R.... Collins F.S. (1990)
56. The neurofibromatosis type 1 gene encodes a protein related to GAP. (PubMed id 2116237)^{1, 2} Xu G.... Weiss R. (1990)
57. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. (PubMed id 2121370)^{1, 2} Martin G.A.... McCormick F. (1990)
58. Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia. (PubMed id 11727265)^{1, 9} Sakamoto A....Tsuneyoshi M. (2001)
59. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. (PubMed id 9639526)^{1, 9} Side L.E....Shannon K.M. (1998)
60. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2. (PubMed id 18218617)^{1, 9} Patrakitkomjorn S....Araki N. (2008)
61. Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations. (PubMed id 19048115)^{1, 9} Sangha N....Cho K.R. (2008)
62. Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis. (PubMed id 12199909)^{1, 9} Malminen M....Peltonen J. (2002)
63. Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I. (PubMed id 7519874)^{1, 9} Gutmann D.H....Collins F.S. (1994)
64. NF1 microduplication first clinical report: association with mild mental retardation, early onset of baldness and dental enamel hypoplasia? (PubMed id 18183042)^{1, 9} Grisart B....Destree A. (2008)
65. Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein. (PubMed id 15988004)^{1, 9} Yang G....Hiebert S.W. (2005)
66. NF1 tumor suppressor mRNA is targeted to the cell-cell contact zone in Ca(2+)-induced keratinocyte differentiation. (PubMed id 11896214)^{1, 9} Yla-Outinen H....Peltonen J. (2002)
67. Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin. (PubMed id 8176268)^{1, 9} Malhotra R. and Ratner N. (1994)
68. The RasGAP proteins Ira2 and neurofibromin are negati vely regulated by Gpb1 in yeast and ETEA in humans. (PubMed id 20160012)^{1, 9} Phan V.T....McCormick F. (2010)
69. The R1947X mutation of NF1 causing autosomal dominant neurofibromatosis type 1 in a Chinese family. (PubMed id 18407053)^{1, 9} Yang Q....Liu M. (2008)
70. PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells. (PubMed id 17200120)^{1, 9} Huang W....Eklund E.A. (2007)
71. Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein. (PubMed id 16914719)^{1, 9} Huang W....Eklund E.A. (2006)
72. Characterisation of the interaction between syndecan- 2, neurofibromin and CASK: dependence of interaction on syndecan dimerization. (PubMed id 20006588)^{1, 9} Volta M....Roberts R.G. (2010)
73. A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene. (PubMed id 18948576)^{1, 9} Yin B....Largaespada D.A. (2009)
74. [NF1 mutation analysis in a Chinese family with neuro- fibromatosis type] (PubMed id 18331998)^{1, 9} Huang Y.H....Liu M.G. (2008)
75. The expression of neurofibromin in human osteoblasts and chondrocytes. (PubMed id 18316778)^{1, 9} Chen H....Ma W. (2008)
76. Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. (PubMed id 17668375)^{1, 9} Maertens O....Messiaen L. (2007)
77. Angiogenic expression profile of normal and neurofibromin-deficient human Schwann cells. (PubMed id 17404841)^{1, 9} Thomas S.L. and De Vries G.H. (2007)
78. Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt. (PubMed id 16405917)^{1, 9} Boyanapalli M....Mikol D.D. (2006)
79. Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles. (PubMed id 8628317)^{1, 9} Morcos P....Tamanoi F. (1996)
80. RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A. (PubMed id 18592002)^{1, 9} Ahlquist T....Lothe R.A. (2008)
81. Functional analysis of splicing mutations in exon 7 of NF1 gene. (PubMed id 17295913)^{1, 9} Bottillo I....Dallapiccola B. (2007)
82. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11. (PubMed id 17353900)^{1, 9} Flotho C....Niemeyer C.M. (2007)
83. The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis. (PubMed id 12191989)^{1, 9} Hakimi M.A....Shiekhattar R. (2002)
84. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. (PubMed id 1570015)^{1, 9} Basu T.N....Downward J. (1992)
85. Loss of SDHB and NF1 genes in a malignant phyllodes t umor of the breast as detected by oligo-array comparative genomic hybridization . (PubMed id 20082856)^{1, 9} Lee J....Li S. (2010)
86. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. (PubMed id 16648142)^{1, 9} Munchhof A.M....Ingram D.A. (2006)
87. The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway. (PubMed id 16169856)^{1, 9} Ozawa T....Saya H. (2005)
88. A nonsense mutation at Arg-1947 in the NF1 gene in a case of neurofibromatosis type 1 in a Korean patient. (PubMed id 10721668)^{1, 9} Park K.C....Eun H.C. (2000)
89. Familial spinal neurofibromatosis: clinical and DNA linkage analysis. (PubMed id 1745350)^{1, 9} Pulst S.M....Korenberg J.R. (1991)
90. Genetic and cellular evidence of vascular inflammatio n in neurofibromin-deficient mice and humans. (PubMed id 20160346)^{1, 9} Lasater E.A....Ingram D.A. (2010)
91. The neurofibromatosis type 1 tumor suppressor control s cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo. (PubMed id 20124472)^{1, 9} Banerjee S....Gutmann D.H. (2010)
92. Mitotic recombination and compound-heterozygous mutat ions are predominant NF1-inactivating mechanisms in children with juvenile myel omonocytic leukemia and neurofibromatosis type 1. (PubMed id 20015894)^{1, 9} Steinemann D....Flotho C. (2010)
93. Schweinfurthin A selectively inhibits proliferation a nd Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GR D-dependent manner. (PubMed id 20442305)^{1, 9} Turbyville T.J....Reilly K.M. (2010)
94. Integrated genomic analysis identifies clinically rel evant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. (PubMed id 20129251)^{1, 9} Verhaak R.G....Hayes D.N. (2010)
95. Effect on the Ras/Raf signaling pathway of post-trans lational modifications of neurofibromin: in silico study of protein modificatio n responsible for regulatory pathways. (PubMed id 19718661)^{1, 9} (2009)
96. A severe form of Noonan syndrome and autosomal dominant cafAc-au-lait spots - evidence for different genetic origins. (PubMed id 19120036)^{1, 9} NystrAPm A.M....Bondeson M.L. (2009)
97. Genome wide molecular analysis of minimally different iated acute myeloid leukemia. (PubMed id 19773259)^{1, 9} Silva F.P....Giphart-Gassler M. (2009)
98. Developmental abnormalities and cancer predisposition in neurofibromatosis type 1. (PubMed id 19601812)^{1, 9} Larizza L....Riva P. (2009)
99. Regulation of the Ras-GTPase activating protein neurofibromin by C-tail phosphorylation: implications for protein kinase C/Ras/extracellular signal-regulated kinase 1/2 pathway signaling and neuronal differentiation. (PubMed id 19220708)^{1, 9} Leondaritis G....Mangoura D. (2009)
100. Somatic mutation analysis in NF1 cafe au lait spots reveals two NF1 hits in the melanocytes. (PubMed id 17914445)^{1, 9} De Schepper S....Messiaen L. (2008)
101. Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential. (PubMed id 19041782)^{1, 9} Williams J.P....Ratner N. (2008)
102. Growth-dependent repression of human adenine nucleotide translocator-2 (ANT2) transcription: evidence for the participation of Smad and Sp family proteins in the NF1-dependent repressor complex. (PubMed id 18215124)^{1, 9} Luciakova K....Nelson B.D. (2008)
103. Denaturing High Performance Liquid Chromatography Detection of SDHB, SDHD, and VHL Germline Mutations in Pheochromocytoma. (PubMed id 19215943)^{1, 9} Meyer-Rochow G.Y....Benn D.E. (2008)
104. A novel mutation in the NF1 gene in two siblings with neurofibromatosis type 1 and bilateral optic pathway glioma. (PubMed id 17514731)^{1, 9} Kebudi R....Yazici H. (2008)
105. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways. (PubMed id 17096025)^{1, 9} Shapira S....Stein R. (2007)
106. Microsatellite abnormalities and somatic down-regulation of mismatch repair characterize nodular-trabecular muscle-invasive urothelial carcinoma of the bladder. (PubMed id 17880527)^{1, 9} Rubio J....Diaz-Cano S.J. (2007)
107. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. (PubMed id 17160901)^{1, 9} Upadhyaya M....Messiaen L. (2007)
108. Reconstitution of the NF1 GAP-related domain in NF1-deficient human Schwann cells. (PubMed id 16908010)^{1, 9} Thomas S.L....De Vries G.H. (2006)
109. Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells. (PubMed id 16644864)^{1, 9} Li F....Ingram D.A. (2006)
110. Identification of forty-five novel and twenty-three known NF1 mutations in Chinese patients with neurofibromatosis type 1. (PubMed id 16835897)^{1, 9} Lee M.J....Yu C.L. (2006)
111. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience. (PubMed id 17102080)^{1, 9} Korpershoek E....Dinjens W.N. (2006)
112. Independent NF1 mutations in two large families with spinal neurofibromatosis. (PubMed id 12566521)^{1, 9} Messiaen L....Poyhonen M. (2003)
113. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. (PubMed id 12807981)^{1, 9} Ars E....Lazaro C. (2003)
114. Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. (PubMed id 12152785)^{1, 9} Perry A....Gutmann D.H. (2002)
115. Tandem duplication within the neurofibromatosis type 1 gene (NF1) and reciprocal t(15;16)(q26.3;q12.1) translocation in familial association of NF1 with intestinal neuronal dysplasia type B (IND B) (PubMed id 10712107)^{4, 9} Bahuau M....Vidaud D. (2000)
116. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. (PubMed id 11140831)^{1, 9} Hamilton S.J. and Friedman J.M. (2000)
117. NF1 gene analysis focused on CpG-rich exons in a cohort of 93 patients with neurofibromatosis type 1. (PubMed id 10980545)^{2, 9} Boulandet E.G....Wolkenstein P. (2000)
118. Developmental regulation of a neuron-specific neurofibromatosis 1 isoform. (PubMed id 10553997)^{1, 9} Gutmann D.H....Hirbe A. (1999)
119. Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma. (PubMed id 10451710)^{4, 9} Kluwe L....Mautner V.F. (1999)
120. Neurofibromatosis type 1: piecing the puzzle together. (PubMed id 9706718)^{1, 9} Feldkamp M.M....Guha A. (1998)
121. Recurrent 2-bp deletion in exon 10c of the NF1 gene in two cases of von Recklinghausen neurofibromatosis. (PubMed id 8664912)^{1, 9} Robinson P.N....Nurnberg P. (1996)
122. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. (PubMed id 1550670)^{1, 9} Daston M.M....Ratner N. (1992)
123. Internal tumor burden in neurofibromatosis Type I pati ents with large NF1 deletions. (PubMed id 22294457)¹ Kluwe L....Mautner V.F. (2012)
124. Neoplasms associated with germline and somatic NF1 gen e mutations. (PubMed id 22240541)¹ Patil S. and Chamberlain R.S. (2012)
125. Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis. (PubMed id 22945628)¹ Dai C....Lindquist S. (2012)
126. Tissue-specific differences in the proportion of mosai c large NF1 deletions are suggestive of a selective growth advantage of hematopo ietic del(+/-) stem cells. (PubMed id 22190464)¹ Roehl A.C....Kehrer-Sawatzki H. (2012)
127. Is double inactivation of the Nf1 gene responsible for the development of congenital pseudarthrosis of the tibia associated with NF1? (PubMed id 22488919)¹ Lee S.M....Cho T.J. (2012)
128. Dissecting the clinical phenotype associated with mosa ic type-2 NF1 microdeletions. (PubMed id 22581253)¹ Kehrer-Sawatzki H....Mautner V.F. (2012)
129. A fraction of neurofibromin interacts with PML bodies in the nucleus of the CCF astrocytoma cell line. (PubMed id 22293200)¹ Godin F....Benedetti H. (2012)
130. Functional proteomics establishes the interaction of S IRT7 with chromatin remodeling complexes and expands its role in regulation of R NA polymerase I transcription. (PubMed id 22586326)¹ Tsai Y.C....Cristea I.M. (2012)
131. The neurofibromin 1 type I isoform predominance charac terises female population affected by sporadic breast cancer: preliminary data. (PubMed id 22412049)¹ Marrero D....Salcedo M. (2012)
132. Screening for mutation site on the type I neurofibroma tosis gene in a family. (PubMed id 22207399)¹ Lv M....Li S. (2012)
133. Biallelic inactivation of NF1 in a sporadic plexiform neurofibroma. (PubMed id 22585738)¹ Beert E....Debiec-Rychter M. (2012)
134. Cone-rod dystrophy associated with amelogenesis imperf ecta in a child with neurofibromatosis type 1. (PubMed id 21728811)¹ Zobor D....Kohl S. (2012)
135. NF1 microduplications: identification of seven nonrela ted individuals provides further characterization of the phenotype. (PubMed id 22241097)¹ Moles K.J....Shaffer L.G. (2012)
136. Neurofibromin modulates adult hippocampal neurogenesis and behavioral effects of antidepressants. (PubMed id 22399775)¹ Li Y....Parada L.F. (2012)
137. Sensitivity of glioblastomas to clinically available M EK inhibitors is defined by neurofibromin 1 deficiency. (PubMed id 22573716)¹ See W.L....Pieper R.O. (2012)
138. A shared molecular mechanism underlies the human rasop athies Legius syndrome and Neurofibromatosis-1. (PubMed id 22751498)¹ Stowe I.B....McCormick F. (2012)
139. Mitotic recombination of chromosome arm 17q as a cause of loss of heterozygosity of NF1 in neurofibromatosis type 1-associated glomus tumors. (PubMed id 22250039)¹ Stewart D.R....Legius E. (2012)
140. PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors. (PubMed id 22700876)¹ Keng V.W....Largaespada D.A. (2012)
141. Deletion of the tumor-suppressor gene NF1 occurs in 5% of myeloid malignancies and is accompanied by a mutation in the remaining allel e in half of the cases. (PubMed id 22015770)¹ Haferlach C....Haferlach T. (2012)
142. The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently acco mpanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates a dverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML. (PubMed id 21283084)¹ Haferlach C....Schnittger S. (2011)
143. Neurofibromin (Nf1) is required for skeletal muscle d evelopment. (PubMed id 21478499)¹ Kossler N....Kolanczyk M. (2011)
144. S100B and neurofibromin immunostaining and X-inactiva tion patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas. (PubMed id 21674567)¹ Tucker T....Friedman J.M. (2011)
145. Immune response and mitochondrial metabolism are commo nly deregulated in DMD and aging skeletal muscle. (PubMed id 22096509)¹ Baron D....Pereon Y. (2011)
146. A molecular analysis of individuals with neurofibroma tosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genot ype-phenotype correlations. (PubMed id 21278392)¹ Sharif S....Evans D.G. (2011)
147. Structural and biochemical consequences of NF1 associ ated nontruncating mutations in the Sec14-PH module of neurofibromin. (PubMed id 21089070)¹ Welti S....Scheffzek K. (2011)
148. Mass spectrometric analysis of lysine ubiquitylation r eveals promiscuity at site level. (PubMed id 21139048)¹ Danielsen J.M....Nielsen M.L. (2011)
149. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. (PubMed id 21406692)² Rigbolt K.T....Blagoev B. (2011)
150. Mosaic type-1 NF1 microdeletions as a cause of both g eneralized and segmental neurofibromatosis type-1 (NF1). (PubMed id 21280148)¹ Messiaen L....Kehrer-Sawatzki H. (2011)
151. Perinatal or adult Nf1 inactivation using tamoxifen-i nducible PlpCre each cause neurofibroma formation. (PubMed id 21551249)¹ Mayes D.A....Ratner N. (2011)
152. The NF1 gene contains hotspots for L1 endonuclease-dep endent de novo insertion. (PubMed id 22125493)¹ Wimmer K....Messiaen L. (2011)
153. A proteome-wide, quantitative survey of in vivo ubiqui tylation sites reveals widespread regulatory roles. (PubMed id 21890473)¹ Wagner S.A....Choudhary C. (2011)
154. The probable cell of origin of NF1- and PDGF-driven gl ioblastomas. (PubMed id 21931722)¹ Hambardzumyan D....Michor F. (2011)
155. Valosin-containing protein and neurofibromin interact to regulate dendritic spine density. (PubMed id 22105171)¹ Wang H.F....Hsueh Y.P. (2011)
156. Neurofibromatosis-1 heterozygosity increases microgli a in a spatially and temporally restricted pattern relevant to mouse optic glio ma formation and growth. (PubMed id 21157378)¹ Simmons G.W....Gutmann D.H. (2011)
157. Initial characterization of the human central proteome. (PubMed id 21269460)² Burkard T.R.... Colinge J. (2011)
158. Absence of exon 17 c.2970-2872delAAT mutation in Turki sh NF1 patients with mild phenotype. (PubMed id 21732117)¹ Terzi Y.K....Ayter S. (2011)
159. Familial spinal neurofibromatosis due to a multiexoni c NF1 gene deletion. (PubMed id 21365283)¹ Pizzuti A....Dallapiccola B. (2011)
160. TGF-I^ signals the formation of a unique NF1/Smad4-dep endent transcription repressor-complex in human diploid fibroblasts. (PubMed id 21782795)¹ Luciakova K....Nelson B.D. (2011)
161. Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. (PubMed id 21838856)² Ponti G.... Seidenari S. (2011)
162. A functional tetranucleotide (AAAT) polymorphism in a n Alu element in the NF1 gene is associated with mental retardation. (PubMed id 21236316)¹ VAcdrine S.M....Andres C.R. (2011)
163. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. (PubMed id 21903422)¹ Li S....Dorf M.E. (2011)
164. A novel NF1 gene mutation in an Italian family with n eurofibromatosis type 1. (PubMed id 20927530)¹ Gabriele A.L....Quattrone A. (2011)
165. Variable expression of neurofibromatosis 1 in monozyg otic twins. (PubMed id 21337692)¹ Rieley M.B....Schorry E.K. (2011)
166. The role of motor proficiency in bone health in genet ic syndromes. (PubMed id 21244408)¹ Stevenson D.A. (2011)
167. Protein interaction domain mapping of human kinetocho re protein Blinkin reveals a consensus motif for binding of spindle assembly ch eckpoint proteins Bub1 and BubR1. (PubMed id 21199919)¹ Kiyomitsu T....Yanagida M. (2011)
168. Germline mosaicism in neurofibromatosis type 1 due to a paternally derived multi-exon deletion. (PubMed id 20503322)¹ Bottillo I....Dallapiccola B. (2010)
169. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. (PubMed id 20379614)¹ Rose J.E....Uhl G.R. (2010)
170. Intrachromosomal mitotic nonallelic homologous recomb ination is the major molecular mechanism underlying type-2 NF1 deletions. (PubMed id 20725927)¹ Roehl A.C....Kehrer-Sawatzki H. (2010)
171. The role of neurofibromin in N-Ras mediated AP-1 regu lation in malignant peripheral nerve sheath tumors. (PubMed id 20680410)¹ Kraniak J.M....Tainsky M.A. (2010)
172. AML with CBFB-MYH11 rearrangement demonstrate RAS pat hway alterations in 92% of all cases including a high frequency of NF1 deletion s. (PubMed id 20164853)¹ Haferlach C....Haferlach T. (2010)
173. Neurofibromin regulates corticostriatal inhibitory ne tworks during working memory performance. (PubMed id 20624961)¹ Shilyansky C....Silva A.J. (2010)
174. Pediatric early T-cell precursor leukemia with NF1 de letion and high-sensitivity in vitro to tipifarnib. (PubMed id 20428205)¹ Biagi C....Pession A. (2010)
175. Single nucleotide polymorphisms of matrix metalloprot einase 9 (MMP-9) and tumour protein 73 (TP73) interact with Epstein Barr virus in chronic lymphocytic leukemia: results from the European case-control study E piLymph. (PubMed id 21048031)¹ Casabonne D....de Sanjose S. (2010)
176. NF1 is a tumor suppressor in neuroblastoma that deter mines retinoic acid response and disease outcome. (PubMed id 20655465)¹ HAPlzel M....Bernards R. (2010)
177. Clinical characterisation of 29 neurofibromatosis typ e-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. (PubMed id 20543202)¹ Mautner V.F....Kehrer-Sawatzki H. (2010)
178. NF1 inactivation in adult acute myelogenous leukemia. (PubMed id 20505189)¹ Parkin B....Malek S.N. (2010)
179. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1. (PubMed id 20002172)¹ Arima Y....Saya H. (2010)
180. Genomic profiling of adult acute lymphoblastic leukem ia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia. (PubMed id 20435627)¹ Okamoto R....Koeffler H.P. (2010)
181. Extended runs of homozygosity at 17q11.2: an associat ion with type-2 NF1 deletions? (PubMed id 20052761)¹ Roehl A.C....Kehrer-Sawatzki H. (2010)
182. Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5' untransla ted region, exon and intron 1. (PubMed id 21142935)¹ Harder A....Peters H. (2010)
183. NF1 exon 22 analysis of individuals with the clinical diagnosis of neurofibromatosis type 1. (PubMed id 20602485)¹ Muram-Zborovski T.M....Stevenson D.A. (2010)
184. NF1 inactivation revs up Ras in adult acute myelogeno us leukemia. (PubMed id 20587590)¹ Mullally A. and Ebert B.L. (2010)
185. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. (PubMed id 20513137)¹ Pasmant E....Vidaud D. (2010)
186. [Developmental manifestation in children with neurofi bromatosis type 1] (PubMed id 20422842)¹ Cohen R. and Shuper A. (2010)
187. Nuclear factor 1 synergizes with progesterone recepto r on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetr amer by facilitating access to the central hormone-responsive elements. (PubMed id 19940123)¹ Vicent G.P....Beato M. (2010)
188. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. (PubMed id 20068231)² Olsen J.V....Mann M. (2010)
189. Variation at the NFATC2 locus increases the risk of t hiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipr il and rosiglitazone Medication (DREAM) study. (PubMed id 20628086)¹ Bailey S.D....Anand S. (2010)
190. Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells. (PubMed id 20571392)¹ Staser K....Clapp D.W. (2010)
191. Analysis of NF1 somatic mutations in cutaneous neurof ibromas from patients with high tumor burden. (PubMed id 20358387)¹ Thomas L....Upadhyaya M. (2010)
192. Monozygotic twins with Neurofibromatosis type 1, conc ordant phenotype and synchronous development of MPNST and metastasis. (PubMed id 20687928)¹ Melean G....HernA!ndez-Chico C. (2010)
193. Unravelling the genetic basis of variable clinical ex pression in neurofibromatosis 1. (PubMed id 19417008)¹ Sabbagh A....Wolkenstein P. (2009)
194. Neurofibromatosis type 1 with undescribed osseous abn ormalities: new features? (PubMed id 19238080)¹ Leruste A....Lacombe D. (2009)
195. Large-scale proteomics analysis of the human kinome. (PubMed id 19369195)² Oppermann F.S.... Daub H. (2009)
196. Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours. (PubMed id 19142971)¹ Bottillo I....Dallapiccola B. (2009)
197. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome. (PubMed id 19449407)¹ Thiel C....Rauch A. (2009)
198. Neurofibromatosis type 1 and infantile spasms. (PubMed id 18802710)¹ Ruggieri M....Pavone L. (2009)
199. Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression. (PubMed id 19061981)¹ LeskelAo H.V....Peltonen J. (2009)
200. RNF135 mutations are not present in patients with Sotos syndrome-like features. (PubMed id 19291764)¹ Visser R....Losekoot M. (2009)
201. The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas. (PubMed id 19221814)¹ Upadhyaya M....Mautner V. (2009)
202. Genetic mutations associated with cigarette smoking in pancreatic cancer. (PubMed id 19351817)¹ Blackford A....Hruban R.H. (2009)
203. Low U1 snRNP dependence at the NF1 exon 29 donor splice site. (PubMed id 19292874)¹ Raponi M....Baralle D. (2009)
204. Gene-centric association signals for lipids and apoli poproteins identified via the HumanCVD BeadChip. (PubMed id 19913121)¹ Talmud P.J.... . (2009)
205. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. (PubMed id 19690332)² Mayya V.... Han D.K. (2009)
206. Frequent genomic abnormalities in acute myeloid leuke mia/myelodysplastic syndrome with normal karyotype. (PubMed id 19144660)¹ Akagi T....Koeffler H.P. (2009)
207. Reproductive decisions after prenatal diagnosis in ne urofibromatosis type 1: importance of genetic counseling. (PubMed id 19650418)¹ Terzi Y.K....Ayter S. (2009)
208. Regulation of neuron-specific alternative splicing of neurofibromatosis type 1 pre-mRNA. (PubMed id 18086893)¹ Zhu H....Lou H. (2008)
209. Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis. (PubMed id 18220336)² Cantin G.T....Yates J.R. III (2008)
210. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs). (PubMed id 17960768)¹ Upadhyaya M....Mautner V. (2008)
211. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. (PubMed id 18172006)¹ Balgobind B.V....Meijerink J.P. (2008)
212. Nature and mRNA effect of 282 different NF1 point mut ations: focus on splicing alterations. (PubMed id 18546366)¹ Pros E....LA!zaro C. (2008)
213. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. (PubMed id 18691976)² Daub H.... Mann M. (2008)
214. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes? (PubMed id 18511569)¹ Kehrer-Sawatzki H. and Cooper D.N. (2008)
215. A quantitative atlas of mitotic phosphorylation. (PubMed id 18669648)² Dephoure N.... Gygi S.P. (2008)
216. Germline and somatic NF1 gene mutations in plexiform neurofibromas. (PubMed id 18484666)¹ Upadhyaya M....Mautner V. (2008)
217. The pathological splicing mutation c.6792C>G in NF1 exon 37 causes a change of tenancy between antagonistic splicing factors. (PubMed id 18503770)¹ Skoko N....Baralle F.E. (2008)
218. Neurofibromatosis type I: genetics and clinical manifestations. (PubMed id 18214791)¹ Savar A. and Cestari D.M. (2008)
219. Alphavirus production is inhibited in neurofibromin 1-deficient cells through activated RAS signalling. (PubMed id 18485440)¹ Kolokoltsova O.A....Watowich S.J. (2008)
220. Copy number variations in the NF1 gene region are infrequent and do not predispose to recurrent type-1 deletions. (PubMed id 18212816)¹ Steinmann K....Kehrer-Sawatzki H. (2008)
221. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. (PubMed id 17426081)¹ Bausch B....Neumann H.P. (2007)
222. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning. (PubMed id 17299016)¹ Hyman S.L....North K.N. (2007)
223. An orthotopic xenograft model of intraneural NF1 MPNST suggests a potential association between steroid hormones and tumor cell proliferation. (PubMed id 17876295)¹ Perrin G.Q....Muir D. (2007)
224. Neurofibromatosis: novel and recurrent mutations in Turkish patients. (PubMed id 18021924)¹ Terzi Y.K....Ayter S. (2007)
225. Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation. (PubMed id 17581973)¹ Ho I.S....Zhong Y. (2007)
226. Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene. (PubMed id 16944271)¹ Stewart W....Tobias E.S. (2007)
227. Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. (PubMed id 18055911)¹ De Luca A....Dallapiccola B. (2007)
228. Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. (PubMed id 17216419)¹ Hawes J.J....Reilly K.M. (2007)
229. Novel mutations in the NF1 gene in Czech patients with neurofibromatosis type 1. (PubMed id 17726231)¹ Bendova S....Marikova T. (2007)
230. Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination. (PubMed id 17999360)¹ Steinmann K....Kehrer-Sawatzki H. (2007)
231. Tumor LOH analysis provides reliable linkage information for prenatal genetic testing of sporadic NF1 patients. (PubMed id 17563086)¹ Serra E....Lazaro C. (2007)
232. Molecular diagnosis of neurofibromatosis type 1: 2 years experience. (PubMed id 16944272)¹ Griffiths S....Upadhyaya M. (2007)
233. Novel NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor. (PubMed id 16741618)¹ Nemoto H....Sanada Y. (2006)
234. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. (PubMed id 16344560)¹ Kimura K.... Sugano S. (2006)
235. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. (PubMed id 16835260)¹ Yang F.C....Clapp D.W. (2006)
236. Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literature. (PubMed id 16467218)¹ Mensink K.A....Babovic-Vuksanovic D. (2006)
237. Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions. (PubMed id 17053831)¹ Yang F.C....Clapp D.W. (2006)
238. An extended consensus motif enhances the specificity of substrate modification by SUMO. (PubMed id 17036045)¹ Yang S.H....Sharrocks A.D. (2006)
239. Functional splicing assay shows a pathogenic intronic mutation in neurofibromatosis type 1 (NF1) due to intronic sequence exonization. (PubMed id 16470740)¹ Raponi M....Baralle D. (2006)
240. Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes. (PubMed id 16374483)¹ De Schepper S....Lambert J.L. (2006)
241. Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients. (PubMed id 16830335)¹ De Raedt T....Legius E. (2006)
242. Double inactivation of NF1 in tibial pseudarthrosis. (PubMed id 16773574)¹ Stevenson D.A....Viskochil D.H. (2006)
243. The consensus coding sequences of human breast and colorectal cancers. (PubMed id 16959974)² Sjoeblom T.... Velculescu V.E. (2006)
244. DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. (PubMed id 16625196)² Zody M.C.... Nusbaum C. (2006)
245. Identification of novel deletion breakpoints bordered by segmental duplications in the NF1 locus using high resolution array-CGH. (PubMed id 15944227)¹ Mantripragada K.K....Dumanski J.P. (2006)
246. The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1. (PubMed id 16479075)¹ Jeong S.Y....Kim H.J. (2006)
247. Phosphoproteome analysis of the human mitotic spindle. (PubMed id 16565220)¹ Nousiainen M.... Koerner R. (2006)
248. Neurofibromin: a general outlook. (PubMed id 16813595)¹ Trovo-Marqui A.B. and Tajara E.H. (2006)
249. Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient. (PubMed id 15948193)² Bertola D.R.... Krieger J.E. (2005)
250. BAF complex is closely related to and interacts with NF1/CTF and RNA polymerase II in gene transcriptional activation. (PubMed id 15999204)¹ Zhao L.H....Zeng X.L. (2005)
251. TATA-binding protein (TBP)-like factor (TLF) is a fun ctional regulator of transcription: reciprocal regulation of the neurofibromato sis type 1 and c-fos genes by TLF/TRF2 and TBP. (PubMed id 15767669)¹ Chong J.A....Clapham D.E. (2005)
252. Evidence by expression analysis of candidate genes fo r congenital heart defects in the NF1 microdeletion interval. (PubMed id 16138909)¹ Venturin M....Riva P. (2005)
253. Global phosphoproteome of HT-29 human colon adenocarcinoma cells. (PubMed id 16083285)¹ Kim J.-E.... White F.M. (2005)
254. An isochore transition zone in the NF1 gene region is a conserved landmark of chromosome structure and function. (PubMed id 16081245)¹ Schmegner C....Assum G. (2005)
255. The effect of extracellular calcium concentration on calcium-mediated cell signaling in NF1 tumor suppressor-deficient keratinocytes. (PubMed id 15735964)¹ Korkiamaki T....Peltonen J. (2005)
256. Palindromic AT-rich repeat in the NF1 gene is hypervariable in humans and evolutionarily conserved in primates. (PubMed id 16116616)¹ Inagaki H.... Kurahashi H. (2005)
257. Splicing in action: assessing disease causing sequence changes. (PubMed id 16199547)¹ Baralle D. and Baralle M. (2005)
258. Two novel mutations of the NF1 gene in Chinese Han families with type 1 neurofibromatosis. (PubMed id 16005615)¹ Cai Y....Wang S. (2005)
259. Genomic organization and evolution of the NF1 microdeletion region. (PubMed id 15233998)¹ De Raedt T....Legius E. (2004)
260. Large-scale characterization of HeLa cell nuclear phosphoproteins. (PubMed id 15302935)¹ Beausoleil S.A....Gygi S.P. (2004)
261. Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. (PubMed id 15146197)¹ Brandenberger R.... Stanton L.W. (2004)
262. Expression, purification and preliminary crystallographic characterization of a novel segment from the neurofibromatosis type 1 protein. (PubMed id 15583390)¹ Bonneau F....Scheffzek K. (2004)
263. Neurofibromin is actively transported to the nucleus. (PubMed id 14988005)¹ Vandenbroucke I....Messiaen L. (2004)
264. Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. (PubMed id 14729829)⁴ Venturin M....Riva P. (2004)
265. Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain. (PubMed id 15060124)² Mattocks C....Whittaker J. (2004)
266. Characterization of functional elements in the neurofibromatosis (NF1) proximal promoter region. (PubMed id 14647436)¹ Zou M.X....Rodenhiser D.I. (2004)
267. Presence of the R1748X mutation in the NF1 gene in a Brazilian patient with ectropion uveae. (PubMed id 15627836)¹ Trovo-Marqui A.B....Tajara E.H. (2004)
268. Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions. (PubMed id 15342556)¹ Suzuki Y.... Sugano S. (2004)
269. A new insight into our understanding of neurofibromatosis type 1? (PubMed id 15096131)¹ Chimenti S. (2004)
270. The interferon consensus sequence-binding protein activates transcription of the gene encoding neurofibromin 1. (PubMed id 15371411)¹ Zhu C....Eklund E.A. (2004)
271. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras. (PubMed id 12730209)¹ Yunoue S....Araki N. (2003)
272. Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1. (PubMed id 14565158)⁴ Tada K....Ushio Y. (2003)
273. NF1 exon 7 skipping and sequence alterations in exonic splice enhancers (ESEs) in a neurofibromatosis 1 patient. (PubMed id 13680360)¹ Colapietro P....Larizza L. (2003)
274. Neurofibromatosis type 1 (NF1): Identification of eight unreported mutations in NF1 gene in Italian patients [corrected]. (PubMed id 12872266)¹ Origone P....Bonioli E. (2003)
275. Elevated risk for MPNST in NF1 microdeletion patients. (PubMed id 12660952)¹ De Raedt T....Legius E. (2003)
276. Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1. (PubMed id 12483293)¹ Upadhyaya M....Cooper D.N. (2003)
277. RT-PCR splicing analysis of the NF1 open reading frame. (PubMed id 12073021)¹ Thomson S.A. and Wallace M.R. (2002)
278. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. (PubMed id 11896613)¹ Singh J....Desprez P.Y. (2002)
279. Linkage disequilibrium and founder effect analysis of the NF1 gene in French Canadians from the Quebec population. (PubMed id 11934389)¹ Fang L.J....Thirion J.P. (2002)
280. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. (PubMed id 12077339)¹ Bajenaru M.L....Gutmann D.H. (2002)
281. Increased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro. (PubMed id 12368469)¹ Kemkemer R....Kaufmann D. (2002)
282. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. (PubMed id 12477932)¹ Strausberg R.L....Marra M.A. (2002)
283. Quantification of NF1 transcripts reveals novel highly expressed splice variants. (PubMed id 12095621)¹ Vandenbroucke I....Messiaen L. (2002)
284. Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas. (PubMed id 12387455)¹ Wimmer K....Pietsch T. (2002)
285. Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13. (PubMed id 12438263)¹ Maris J.M....Shusterman S. (2002)
286. Identification and characterization of four novel large deletions in the human neurofibromatosis type 1 (NF1) gene. (PubMed id 11748857)¹ Fang L.J....Thirion J.P. (2001)
287. Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. (PubMed id 11751683)¹ Gutmann D.H....Parada L.F. (2001)
288. Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans. (PubMed id 11356864)¹ Hsueh Y.P....Roberts R.G. (2001)
289. Genotype analysis of the NF1 gene in the French Canadians from the Quebec population. (PubMed id 11754043)¹ Fang L....Thirion J.P. (2001)
290. Lack of association of the (AAAT)6 allele of the GXAlu tetranucleotide repeat in intron 27b of the NF1 gene with autism. (PubMed id 11449390)⁴ Plank S.M....Michaelis R.C. (2001)
291. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. (PubMed id 11556548)⁴ Kluwe L....Mautner V.F. (2001)
292. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. (PubMed id 10862698)¹ Husi H....Grant S.G. (2000)
293. NF1 gene and neurofibromatosis 1. (PubMed id 10625171)¹ Rasmussen S.A. and Friedman J.M. (2000)
294. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. (PubMed id 10459349)⁴ Kluwe L....Mautner V.F. (1999)
295. Association study of the NF1 gene and autistic disorder. (PubMed id 10581497)⁴ Mbarek O....Andres C. (1999)
296. A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene. (PubMed id 9529361)¹ Ars E....Estivill X. (1998)
297. RNA processing and clinical variability in neurofibromatosis type I (NF1). (PubMed id 9300663)¹ Skuse G.R. and Cappione A.J. (1997)
298. Large-scale concatenation cDNA sequencing. (PubMed id 9110174)¹ Yu W.... Gibbs R.A. (1997)
299. A "double adaptor" method for improved shotgun library construction. (PubMed id 8619474)¹ Andersson B.... Gibbs R.A. (1996)
300. Characterization of a cytogenetic 17q11.2 deletion in an NF1 patient with a contiguous gene syndrome. (PubMed id 8931693)¹ Riva P....Larizza L. (1996)
301. Identification and characterization of two novel tetratricopeptide repeat-containing genes. (PubMed id 8836031)¹ Murthy A.E.... Gusella J.F. (1996)
302. Identification of neurofibromatosis 1 (NF1) homologous loci by direct sequencing, fluorescence in situ hybridization, and PCR amplification of somatic cell hybrids. (PubMed id 8825634)¹ Purandare S.M.... Viskochil D. (1995)
303. Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene. (PubMed id 7633452)¹ Danglot G....Bernheim A. (1995)
304. Two further cases of mutation R1947X in the NF1 gene: screening for a relatively common recurrent mutation. (PubMed id 7649559)¹ Lazaro C....Estivill X. (1995)
305. Characterisation of a novel splice donor mutation affecting position +1 in intron 18 of the NF-1 gene. (PubMed id 7633431)¹ Purandare S.M....Connor J.M. (1995)
306. Characterization of four mutations in the neurofibromatosis type 1 gene by denaturing gradient gel electrophoresis (DGGE). (PubMed id 8069310)¹ Valero M.C....Hernandez-Chico C. (1994)
307. Screening for truncated NF1 proteins. (PubMed id 7874161)¹ Heim R.A....Luce M.C. (1994)
308. Nonsense mutations at Arg-1947 in two cases of familial neurofibromatosis type 1 in Japanese. (PubMed id 7903661)¹ Horiuchi T....Fujita S. (1994)
309. DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse. (PubMed id 7959746)¹ Hajra A.... Collins F.S. (1994)
310. Neurofibromatosis 1 (PubMed id 20301288)¹ Friedman J.M. (1993)
311. An exon-trapping system with a newly constructed trapping vector pEXT2; its application to the proximal region of the human chromosome 21 long arm. (PubMed id 7686513)¹ Ozawa N.... Suzuki H. (1993)
312. Cyclic amplification and selection of targets for multicomponent complexes: myogenin interacts with factors recognizing binding sites for basic helix-loop-helix, nuclear factor 1, myocyte-specific enhancer-binding factor 2, and COMP1 factor. (PubMed id 1329097)¹ Funk W.D. and Wright W.E. (1992)
313. Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1. (PubMed id 1757093)¹ Estivill X....Ravella A. (1991)
314. A small deletion and an adjacent base exchange in a potential stem-loop region of the neurofibromatosis 1 gene. (PubMed id 1937470)¹ Stark M....Krone W. (1991)
315. A de novo Alu insertion results in neurofibromatosis type 1. (PubMed id 1719426)¹ Wallace M.R....Collins F.S. (1991)
316. Precise localization of NF1 to 17q11.2 by balanced translocation. (PubMed id 2491776)¹ Ledbetter D.H....Carey J.C. (1989)
317. Regulation of neurofibromin expression in rat sciatic nerve and cultured Schwann cells. (PubMed id 8847098)⁹ Wrabetz L....Ratner N. (1995)
318. NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. (PubMed id 15840687)⁹ Cacev T....Kapitanovic S. (2005)
319. Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons. (PubMed id 11675125)⁹ Li C....Mangoura D. (2001)
320. Somatic alterations of the NF1 gene in an NF1 individual with multiple benign tumours (internal and external) and malignant tumour types. (PubMed id 17551851)⁹ Spurlock G....Upadhyaya M. (2007)
321. Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient. (PubMed id 16861979)⁹ Perren A....Komminoth P. (2006)
322. Biallelic somatic inactivation of the NF1 gene through chromosomal translocations in a sporadic neurofibroma. (PubMed id 15986446)⁹ Storlazzi C.T....Mertens F. (2005)
323. Germline mutations in NF1 patients with malignancies. (PubMed id 10534774)⁹ Wu R....Legius E. (1999)
324. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes. (PubMed id 14523097)⁹ Dasgupta B....Gutmann D.H. (2003)
325. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro. (PubMed id 10079253)⁹ Aaltonen V....Peltonen J. (1999)
326. Developmental regulation of NF1 tumor suppressor gene in human peripheral nerve. (PubMed id 10659684)⁹ Hirvonen O....Peltonen J. (1998)
327. Neurofibromin: expression by normal human keratinocytes in vivo and in vitro and in epidermal malignancies. (PubMed id 7637322)⁹ Hermonen J....Peltonen J. (1995)
328. Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels. (PubMed id 7609078)⁹ Largaespada D.A....Copeland N.G. (1995)
329. Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis. (PubMed id 1536955)⁹ Shannon K.M....Priest J.R. (1992)
330. Nf1 haploinsufficiency and Icsbp deficiency synergize in the development of leukemias. (PubMed id 19228926)⁹ Koenigsmann J....Carstanjen D. (2009)
331. Inhibition of neurofibromin and p120 GTPase activating protein (GAP) by dietary fatty acids. (PubMed id 10667358)⁹ Lee J.H....Golubic M. (1999)
332. Glial and muscle embryonal carcinoma cell-specific independent regulation of expression of human JC virus early promoter by cyclic AMP response elements and adjacent nuclear factor 1 binding sites. (PubMed id 8818965)⁹ Kumar K.U....Pater A. (1996)
333. Lesional psoriatic epidermis displays reduced neurofibromin immunoreactivity. (PubMed id 7594640)⁹ Peltonen J....Karvonen J. (1995)
334. Regulated expression of neurofibromin in migrating neural crest cells of avian embryos. (PubMed id 7561832)⁹ Stocker K.M....Ciment G. (1995)
335. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. (PubMed id 8302341)⁹ Shannon K.M....McCormick F. (1994)
336. Crosslinking of the surface immunoglobulin receptor in B lymphocytes induces a redistribution of neurofibromin but not p120-GAP. (PubMed id 8290249)⁹ Boyer M.J....Bar-Sagi D. (1994)
337. Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis. (PubMed id 18614544)⁹ Hegedus B....Gutmann D.H. (2008)
338. Mid-aortic syndrome with renovascular hypertension and multisystem involvement in a girl with familiar neurofibromatosis von Recklinghausen type 1. (PubMed id 18063929)⁹ Petrak B....Marikova T. (2007)
339. Detection of novel NF1 mutations and rapid mutation prescreening with Pyrosequencing. (PubMed id 18041031)⁹ Brinckmann A....Nurnberg P. (2007)
340. Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia. (PubMed id 14739366)⁹ Gitler A.D....Epstein J.A. (2004)
341. Molecular characterisation of t(17;22)(q11.2;q11.2) is not consistent with NF1 gene duplication. (PubMed id 12384794)⁹ Kehrer-Sawatzki H....Hameister H. (2002)
342. Identification of two novel frame shift mutations of the NF1 gene in Korean patients with neurofibromatosis type 1. (PubMed id 11068991)⁹ Park K.C....Eun H.C. (2000)
343. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. (PubMed id 10620616)⁹ Ingram D.A....Clapp D.W. (2000)
344. On the lysosomal degradation of neurofibromin and its phosphorylation in cultured melanocytes. (PubMed id 10543444)⁹ Kaufmann D....Muller R. (1999)
345. Differential regulation of neurofibromin and p120 GTPase-activating protein by nutritionally relevant fatty acids. (PubMed id 9589427)⁹ Golubic M....Lee J.H. (1998)
346. Loss of neurofibromin in the leptomeningeal astroglial heterotopia of NF-1. (PubMed id 9568919)⁹ Kato M....Takashima S. (1998)
347. Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors. (PubMed id 9036924)⁹ Griesser J....Krone W. (1997)
348. Reduced expression of neurofibromin in human meningiomas. (PubMed id 9310240)⁹ Sundaram V....Golubic M. (1997)
349. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. (PubMed id 8264632)⁹ Johnson M.R....Lowy D.R. (1994)
350. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras. (PubMed id 8516298)⁹ Johnson M.R....Lowy D.R. (1993)
351. Differences in the interaction of p21c-Ha-ras-GMP-PNP with full-length neurofibromin and GTPase-activating protein. (PubMed id 8437847)⁹ DiBattiste D....Wolfman A. (1993)
352. Neurofibromin is enriched in the endoplasmic reticulum of CNS neurons. (PubMed id 8463837)⁹ Nordlund M....Ratner N. (1993)
353. Detection and characterization of NF1 microdeletions by custom high resolution array CGH. (PubMed id 19767589)⁹ Pasmant E....Vidaud D. (2009)
354. Transcriptional regulation of the 5'-flanking region of the human transcription factor Sp3 gene by NF-1, c-Myb, B-Myb, AP-1 and E2F. (PubMed id 18342022)⁹ Tapias A....Noe V. (2008)
355. Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin. (PubMed id 18213578)⁹ Roth T.M....Barald K.F. (2008)
356. Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. (PubMed id 16314845)⁹ Mangoura D....Vallianatos G. (2006)
357. Extensively high load of internal tumors determined b y whole body MRI scanning in a patient with neurofibromatosis type 1 and a non- LCR-mediated 2-Mb deletion in 17q11.2. (PubMed id 15776250)⁹ Kehrer-Sawatzki H....Mautner V.F. (2005)
358. PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin. (PubMed id 14741381)⁹ Feng L....Araki N. (2004)
359. Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model. (PubMed id 12154062)⁹ Li H....DeClue J.E. (2002)
360. The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. (PubMed id 10383727)⁹ Atit R.P....Ratner N. (1999)
361. Role of neurofibromin in modulation of expression of the tyrosinase-related protein 2 gene. (PubMed id 9792924)⁹ Suzuki H....Shibahara S. (1998)
362. The OMgp gene, a second growth suppressor within the NF1 gene. (PubMed id 9569019)⁹ Habib A.A....Stefansson K. (1998)
363. Do NF1 gene deletions result in a characteristic phenotype? (PubMed id 9375928)⁹ Tonsgard J.H....Lindgren V. (1997)
364. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity. (PubMed id 8816507)⁹ Furlong E.E....Martin F. (1996)
365. Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase. (PubMed id 8612763)⁹ Izawa I....Saya H. (1996)
366. Neurofibromatosis and associated tumour suppressor genes. (PubMed id 8880865)⁹ Zwarthoff E.C. (1996)
367. Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation. (PubMed id 7505343)⁹ Gutmann D.H....Rutkowski J.L. (1993)
368. Progress toward the isolation and characterization of the genes causing neurofibromatosis. (PubMed id 1669691)⁹ Menon A.G....Seizinger B.R. (1990)
369. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. (PubMed id 19573811)⁹ McGillicuddy L.T....Cichowski K. (2009)
370. Characterization of a 7.6-Mb germline deletion encompassing the NF1 locus and about a hundred genes in an NF1 contiguous gene syndrome patient. (PubMed id 18648396)⁹ Pasmant E....Bieche I. (2008)
371. Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras. (PubMed id 16513807)⁹ Hannan F....Zhong Y. (2006)
372. Gene expression profiling of cultured human NF1 heterozygous (NF1+/-) melanocytes reveals downregulation of a transcriptional cis-regulatory network mediating activation of the melanocyte-specific dopachrome tautomerase (DCT) gene. (PubMed id 16033338)⁹ Boucneau J....Lambert J. (2005)
373. Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo. (PubMed id 15944386)⁹ Dasgupta B. and Gutmann D.H. (2005)
374. [Neurofibromatosis type 1 or Von Recklinghausen's dis ease] (PubMed id 15777582)⁹ Pinson S. and Wolkenstein P. (2005)
375. Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse. (PubMed id 12696059)⁹ Jenne D.E....Kehrer-Sawatzki H. (2003)
376. A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve. (PubMed id 12427839)⁹ Rizvi T.A....Ratner N. (2002)
377. Human breast cancer MDA-MB-231 cells fail to express the neurofibromin protein, lack its type I mRNA isoform and show accumulation of P-MAPK and activated Ras. (PubMed id 11566491)⁹ Ogata H....De Luca L.M. (2001)
378. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. (PubMed id 11005256)⁹ Lau N....Guha A. (2000)
379. NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. (PubMed id 10587576)⁹ Dorschner M.O....Stephens K. (2000)
380. Nf1 and Gmcsf interact in myeloid leukemogenesis. (PubMed id 10678181)⁹ Birnbaum R.A....Shannon K.M. (2000)
381. [Clinical diagnosis of neurofibromatosis type 1] (PubMed id 10629698)⁹ Wolkenstein P. and Zeller J. (1999)
382. [NF1 (neurofibromatosis type 1)] (PubMed id 9309135)⁹ Maruta H. and Nur-e-Kamal . (1997)
383. Ullrich-Turner syndrome and neurofibromatosis-1. (PubMed id 8989459)⁹ Schorry E.K....Saal H.M. (1996)
384. Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene. (PubMed id 8665528)⁹ Li Y. and White R. (1996)
385. Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1). (PubMed id 7794530)⁹ Griesser J....Krone W. (1995)
386. Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. (PubMed id 8980005)⁹ Norton K.K....Gutmann D.H. (1995)
387. Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues. (PubMed id 7780179)⁹ Gutmann D.H....Wright D.E. (1995)
388. Multiple transcripts of the neurofibromatosis type 1 gene in human brain and in brain tumours. (PubMed id 7874833)⁹ Takahashi K....Shibahara S. (1994)
389. Functional significance of lysine 1423 of neurofibromin and characterization of a second site suppressor which rescues mutations at this residue and suppresses RAS2Val-19-activated phenotypes. (PubMed id 8264648)⁹ Poullet P....Tamanoi F. (1994)
390. Kinetics of interaction between normal and proline 12 Ras and the GTPase-activating proteins, p120-GAP and neurofibromin. The significance of the intrinsic GTPase rate in determining the transforming ability of ras. (PubMed id 8262937)⁹ Eccleston J.F....Lowe P.N. (1993)
391. Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2. (PubMed id 19336503)⁹ Boedeker C.C....Neumann H.P. (2009)
392. The association of neurofibromatosis, bilateral pheoc hromocytoma and primary hyperparathyroidism. (PubMed id 17647146)⁹ Altinova A.E....Arslan M. (2007)
393. The genetic and molecular pathogenesis of NF1 and NF2. (PubMed id 16818172)⁹ Yohay K.H. (2006)
394. Phylogenetic footprinting reveals evolutionarily conserved regions of the gonadotropin-releasing hormone gene that enhance cell-specific expression. (PubMed id 15319450)⁹ Givens M.L....Mellon P.L. (2004)
395. Neurofibromatosis 1: closing the GAP between mice and men. (PubMed id 12573431)⁹ Dasgupta B. and Gutmann D.H. (2003)
396. Establishing priorities in neurofibromatosis research: a workshop summary. (PubMed id 11388764)⁹ MacCollin M....Finkelstein R. (2001)
397. The neurofibromatoses: when less is more. (PubMed id 11257108)⁹ Gutmann D.H. (2001)
398. Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. (PubMed id 11159187)⁹ Muir D....Wallace M.R. (2001)
399. Neurofibromatosis. Nosological considerations. (PubMed id 12089989)⁹ Badiu C. and Stefanache F. (2000)
400. CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene. (PubMed id 9354454)⁹ Sherman L....Ponta H. (1997)
401. Reduced expression of neurofibromin in the soft tissue tumours obtained from patients with neurofibromatosis type I. (PubMed id 7614817)⁹ Takahashi K....Shibahara S. (1995)
402. Nosological considerations of the neurofibromatoses. (PubMed id 1293176)⁹ Viskochil D. and Carey J.C. (1992)
403. Genetic variants promoting smooth muscle cell prolife ration can result in diffuse and diverse vascular diseases: evidence for a hype rplastic vasculomyopathy. (PubMed id 20130469)⁹ Milewicz D.M....Reid A.J. (2010)
404. Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor pr ognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase p athway. (PubMed id 20062086)⁹ Murayama-Hosokawa S....Aburatani H. (2010)
405. Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray. (PubMed id 18723266)⁹ Kawamata N....Koeffler H.P. (2008)
406. Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity. (PubMed id 17551100)⁹ Alikhani-Koupaei R....Frey F.J. (2007)
407. Topographic molecular profile of pheochromocytomas: role of somatic down-regulation of mismatch repair. (PubMed id 16394087)⁹ Blanes A....Diaz-Cano S.J. (2006)
408. Hypokalemic rhabdomyolysis due to WDHA syndrome caused by VIP-producing composite pheochromocytoma: a case in neurofibromatosis type 1. (PubMed id 16027147)⁹ Onozawa M....Maekawa I. (2005)
409. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. (PubMed id 16098465)⁹ Zhu Y....Parada L.F. (2005)
410. Repression of the human adenine nucleotide translocase-2 gene in growth-arrested human diploid cells: the role of nuclear factor-1. (PubMed id 12777383)⁹ Luciakova K....Nelson B.D. (2003)
411. Retroperitoneal neurofibrosarcoma in a patient with n eurofibromatosis. 2: A case report and review of the literature. (PubMed id 14692188)⁹ Chen Y....Valderrama E. (2003)
412. Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1. (PubMed id 11160381)⁹ Kim H.A....Stiles C.D. (2001)
413. Tumorigenesis in neurofibromatosis: new insights and potential therapies. (PubMed id 11286939)⁹ Reed N. and Gutmann D.H. (2001)
414. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas. (PubMed id 11431704)⁹ Serra E....LA!zaro C. (2001)
415. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. (PubMed id 10973261)⁹ Reilly K.M....Jacks T. (2000)
416. Characterization of the Fugu rubripes NLK and FN5 genes flanking the NF1 (Neurofibromatosis type 1) gene in the 5' direction and mapping of the human counterparts. (PubMed id 10863097)⁹ Kehrer-Sawatzki H....Krone W. (2000)
417. Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder. (PubMed id 10744064)⁹ Diaz-Cano S.J....Wolfe H.J. (2000)
418. Mouse tumor model for neurofibromatosis type 1. (PubMed id 10591653)⁹ Vogel K.S....Parada L.F. (1999)
419. Differential binding of NF1 transcription factor to P53 gene promoter and its depletion in human breast tumours. (PubMed id 10634504)⁹ Nayak B.K. and Das B.R. (1999)
420. Structural analysis of the GAP-related domain from neurofibromin and its implications. (PubMed id 9687500)⁹ Scheffzek K....Wittinghofer A. (1998)
421. Expression of the ERBB2/neu and neurofibromatosis type 1 gene products in reactive and neoplastic schwann cell proliferation. (PubMed id 9824645)⁹ Schlegel J....Ruschoff J. (1998)
422. Contrasting levels of p21ras activation and expression of neurofibromin in peripheral primitive neuroectodermal tumour and neuroblastoma cells, and their response to retinoic acid. (PubMed id 9619634)⁹ Burchill S.A....Lewis I.J. (1998)
423. Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis. (PubMed id 9715282)⁹ Badache A....De Vries G.H. (1998)
424. Targeted delivery of human neurofibromin and c-Raf-1 mutants to the cytoplasmic membrane by use of the influenza virus hemagglutinin. (PubMed id 9128141)⁹ Nur-E-Kamal M.S....Schmidt M.F. (1997)
425. Hereditary spinal neurofibromatosis: a rare form of NF1? (PubMed id 9132486)⁹ Poyhonen M....Leisti J. (1997)
426. Contribution of a nuclear factor 1 binding site to th e glucocorticoid regulation of the cytosolic aspartate aminotransferase gene pr omoter. (PubMed id 8955092)⁹ Garlatti M....Barouki R. (1996)
427. [Heterogeneity of GTPase-activating proteins for Ras in the regulation of Ras signal transduction pathway] (PubMed id 8699317)⁹ Hattori S. and Baba H. (1996)
428. The differential effects of the Gly-60 to Ala mutation on the interaction of H-Ras p21 with different downstream targets. (PubMed id 8626511)⁹ Hwang M.C....Hwang Y.W. (1996)
429. Exon trap analysis of a NF1 splice-site mutation in a chronic myelomonocytic leukemia patient. (PubMed id 7769857)⁹ Ludwig L....Bartram C.R. (1995)
430. The two types of mRNAs for neurofibromin isoforms produced by von Recklinghausen neurofibromatosis (NF1) gene: analysis in human astrocytic tumors. (PubMed id 7501280)⁹ Tokuyama T....Fujita M. (1995)
431. Inhibition of Ras/Raf interaction by anti-oncogenic mutants of neurofibromin, the neurofibromatosis type 1 (NF1) gene product, in cell-free systems. (PubMed id 7499408)⁹ Mori S....Kaziro Y. (1995)
432. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. (PubMed id 7947085)⁹ Cawkwell L....Quirke P. (1994)
433. Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions. (PubMed id 8341688)⁹ Nakafuku M....Kaziro Y. (1993)
434. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. (PubMed id 8328449)⁹ Easton D.F....Ponder B.A. (1993)
435. Genetics of neurofibromatosis 1 in Japan: mutation ra te and paternal age effect. (PubMed id 1351032)⁹ Takano T....Hamaguchi H. (1992)
436. Prevention and control of neurofibromatosis: memorandum from a joint WHO/NNFF meeting. (PubMed id 1600579)⁹ (1992)
437. Molecular characterization of a 17q11.2 translocation in a malignant schwannoma cell line. (PubMed id 1483704)⁹ Reynolds J.E....Diehl S.R. (1992)
438. The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene. (PubMed id 1899288)⁹ Viskochil D.... White R. (1991)
439. Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. (PubMed id 2155400)⁹ Chong T....Bernard H.U. (1990)
440. Germline mutations in TMEM127 confer susceptibility t o pheochromocytoma. (PubMed id 20154675)⁹ Qin Y....Dahia P.L. (2010)
441. Mutations of an E3 ubiquitin ligase c-Cbl but not TET 2 mutations are pathogenic in juvenile myelomonocytic leukemia. (PubMed id 20008299)⁹ Muramatsu H....Maciejewski J.P. (2010)
442. Phaeochromocytoma: state-of-the-art. (PubMed id 20514823)⁹ Donckier J.E. and Michel L. (2010)
443. Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft. (PubMed id 19634141)⁹ Bhola P....Guha A. (2010)
444. Genome-wide transcriptome analyses reveal p53 inactiv ation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. (PubMed id 19890883)⁹ Subramanian S....van de Rijn M. (2010)
445. Gastrointestinal stromal tumor and other primary meta chronous or synchronous neoplasms as a suspicion criterion for syndromic settin g. (PubMed id 20043105)⁹ Ponti G....Conte P.F. (2010)
446. DNA sequence capture and enrichment by microarray fol lowed by next-generation sequencing for targeted resequencing: neurofibromatosi s type 1 gene as a model. (PubMed id 19910506)⁹ Chou L.S....Mao R. (2010)
447. Retroviral insertional mutagenesis identifies Zeb2 ac tivation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mi ce. (PubMed id 20007546)⁹ Caudell D....Aplan P.D. (2010)
448. Juvenile myelomonocytic leukemia: epidemiology, etiop athogenesis, diagnosis, and management considerations. (PubMed id 20034338)⁹ Yoshimi A....Hirano N. (2010)
449. Defective cAMP generation underlies the sensitivity o f CNS neurons to neurofibromatosis-1 heterozygosity. (PubMed id 20410111)⁹ Brown J.A....Gutmann D.H. (2010)
450. The Warburg effect is genetically determined in inher ited pheochromocytomas. (PubMed id 19763184)⁹ Favier J....Gimenez-Roqueplo A.P. (2009)
451. Coexistent intraurothelial carcinoma and muscle-invas ive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair. (PubMed id 19368958)⁹ Blanes A....Diaz-Cano S.J. (2009)
452. Advances in the genetics of glioblastoma: are we reac hing critical mass? (PubMed id 19597514)⁹ Purow B. and Schiff D. (2009)
453. Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis. (PubMed id 19429661)⁹ Laudanski P....Chyczewski L. (2009)
454. Neurofibromatosis type 1 revisited. (PubMed id 19117870)⁹ Williams V.C....Maria B.L. (2009)
455. Polarity based fractionation of fulvic acids. (PubMed id 19782385)⁹ Li A....Wang X. (2009)
456. Neurofibromatosis type 1: should we screen for other genetic syndromes? A case report of co-existence with multiple endocrine neopla sia 2A. (PubMed id 19558618)⁹ Gkaliagkousi E....Douma S. (2009)
457. Two chromatin remodeling activities cooperate during activation of hormone responsive promoters. (PubMed id 19609353)⁹ Vicent G.P....Beato M. (2009)
458. Response and resistance to MEK inhibition in leukaemi as initiated by hyperactive Ras. (PubMed id 19727076)⁹ Lauchle J.O....Shannon K. (2009)
459. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. (PubMed id 19111880)⁹ Alcantara Llaguno S....Parada L.F. (2009)
460. Neurofibromatosis type 1 and associated malignancies. (PubMed id 19348714)⁹ Yohay K. (2009)
461. [Neurofibromatosis type 1 in an adult diagnosed by a pulmonologist] (PubMed id 19890828)⁹ Gawlewicz-Mroczka A....Nizankowska-Mogilnicka E. (2009)
462. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. (PubMed id 19366998)⁹ Pasmant E....France R.N. (2009)
463. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1. (PubMed id 19414372)⁹ Fang Y....Jhanwar S.C. (2009)
464. [Neurofibromatosis type 1: more frequent and severe t hen usually thought] (PubMed id 19750304)⁹ Souza J.F....Rezende N.A. (2009)
465. Identification of two novel mutations in the NF1 gene in Chinese patients with neurofibromatosis type 1. (PubMed id 18643859)⁹ Chen B....Zhang X.J. (2009)
466. Multiple granular cell tumors are an associated feature of LEOPARD syndrome caused by mutation in PTPN11. (PubMed id 19054014)⁹ Schrader K.A....McGillivray B.C. (2009)
467. Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction. (PubMed id 19574548)⁹ Xu J....Epstein J.A. (2009)
468. Glioblastoma subclasses can be defined by activity am ong signal transduction pathways and associated genomic alterations. (PubMed id 19915670)⁹ Brennan C....Holland E. (2009)
469. Gastric schwannoma with adjacent external progression harbored aberrant NF2 gene. (PubMed id 19691769)⁹ Ogasawara N....Joh T. (2009)
470. Solubility survey of fragments of the neurofibromatos is type 1 protein neurofibromin. (PubMed id 19111619)⁹ Bonneau F....Scheffzek K. (2009)
471. [Gastrointestinal stromal tumors in neurofibromatosis type 1] (PubMed id 19144598)⁹ Bajor J. (2009)
472. Mutations in CBL occur frequently in juvenile myelomo nocytic leukemia. (PubMed id 19571318)⁹ Loh M.L....Niemeyer C.M. (2009)
473. Breast cancer susceptibility: current knowledge and implications for genetic counselling. (PubMed id 19092773)⁹ Ripperger T....Schlegelberger B. (2009)
474. A synaptic trek to autism. (PubMed id 19545994)⁹ Bourgeron T. (2009)
475. Neural and cancer stem cells in tumor suppressor mous e models of malignant astrocytoma. (PubMed id 19022744)⁹ Llaguno S.A....Parada L.F. (2008)
476. Cellular retinaldehyde-binding protein-like (CRALBPL), a novel human Sec14p-like gene that is upregulated in human hepatocellular carcinomas, may be used as a marker for human hepatocellular carcinomas. (PubMed id 18271718)⁹ Zhao S....Mao Y. (2008)
477. Pten haploinsufficiency accelerates formation of high-grade astrocytomas. (PubMed id 18451155)⁹ Kwon C.H....Parada L.F. (2008)
478. Microcystic/reticular schwannoma: a distinct variant with predilection for visceral locations. (PubMed id 18520439)⁹ Liegl B....Fletcher C.D. (2008)
479. Association of segmental neurofibromatosis 1 and oculo-auriculo-vertebral spectrum in a 24-year-old female. (PubMed id 18086584)⁹ Castori M....Zambruno G. (2008)
480. Recent advances in the genetics of phaeochromocytoma and functional paraganglioma. (PubMed id 18307724)⁹ Gimenez-Roqueplo A.P....Plouin P.F. (2008)
481. Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes. (PubMed id 18925961)⁹ Gelsi-Boyer V.... Chaffanet M. (2008)
482. Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells. (PubMed id 18768391)⁹ McDaniel A.S....Clapp D.W. (2008)
483. A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors. (PubMed id 18726616)⁹ Yeh I.T....Dahia P.L. (2008)
484. [Achievements of the COMETE program in the genetics of pheochromocytoma] (PubMed id 18663985)⁹ Gimenez-Roqueplo A.P....Plouin P.F. (2008)
485. The mTOR pathway and its role in human genetic diseases. (PubMed id 18598780)⁹ Rosner M....HengstschlAoger M. (2008)
486. The role of steroid hormones in the NF1 phenotype: focus on pregnancy. (PubMed id 18481270)⁹ Roth T.M....Barald K.F. (2008)
487. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia. (PubMed id 18422786)⁹ Koike K. and Matsuda K. (2008)
488. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas. (PubMed id 18510707)⁹ Hrascan R....Karapandza N. (2008)
489. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment. (PubMed id 18663312)⁹ Padidela R....Savage M.O. (2008)
490. Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma. (PubMed id 18316617)⁹ Hegedus B....Gutmann D.H. (2008)
491. Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy. (PubMed id 17236191)⁹ Nebesio T.D....Yang F.C. (2007)
492. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging. (PubMed id 17348023)⁹ Su W....Sherman L.S. (2007)
493. A screen of shRNAs targeting tumor suppressor genes to identify factors involved in A549 paclitaxel sensitivity. (PubMed id 17982636)⁹ Ji D....Weinstein E.J. (2007)
494. Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice. (PubMed id 17090653)⁹ Kim A....Largaespada D.A. (2007)
495. Neurofibromin signaling and synapses. (PubMed id 17370141)⁹ Hsueh Y.P. (2007)
496. Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. (PubMed id 17297459)⁹ Le L.Q. and Parada L.F. (2007)
497. Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth. (PubMed id 17632510)⁹ Douglas J.... Rahman N. (2007)
498. Mitochondrial delivery is essential for synaptic potentiation. (PubMed id 17438209)⁹ Tong J.J. (2007)
499. Neurofibromatosis presenting with a cherubism phenotype. (PubMed id 17120035)⁹ van Capelle C.I....Flanagan A.M. (2007)
500. Recent developments in neurofibromatosis type 1. (PubMed id 17351482)⁹ Lee M.J. and Stephenson D.A. (2007)
501. Elucidating the altered transcriptional programs in breast cancer using independent component analysis. (PubMed id 17708679)⁹ Teschendorff A.E....Caldas C. (2007)
502. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. (PubMed id 17712732)⁹ Janzarik W.G....Omran H. (2007)
503. NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. (PubMed id 17215493)⁹ Dombi E....Widemann B.C. (2007)
504. Gene expression profiling of metastatic brain cancer. (PubMed id 17611651)⁹ Zohrabian V.M....Jhanwar-Uniyal M. (2007)
505. Signal transduction in early heart development (II): ventricular chamber specification, trabeculation, and heart valve formation. (PubMed id 17609502)⁹ Wagner M. and Siddiqui M.A. (2007)
506. Colocalized cellular schwannoma and plexiform neurofibroma in the absence of neurofibromatosis. Case report. (PubMed id 17695403)⁹ Spinner R.J....Gutmann D.H. (2007)
507. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response. (PubMed id 17967772)⁹ Xu J....Epstein J.A. (2007)
508. Role of maxillofacial surgery in patients with neurofibromatosis type I. (PubMed id 17538307)⁹ Fadda M.T....Calvieri S.S. (2007)
509. Conditional N-rasG12V expression promotes manifestations of neurofibromatosis in a mouse model. (PubMed id 17237809)⁹ Saito H....Suzuki N. (2007)
510. Phosphatidylinositol 3-kinase and Akt nonautonomously promote perineurial glial growth in Drosophila peripheral nerves. (PubMed id 17215387)⁹ Lavery W....Stern M. (2007)
511. The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cells. (PubMed id 17222906)⁹ Morgan K.J....Largaespada D.A. (2007)
512. A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A. (PubMed id 17704047)⁹ Bethanis S....Tsagarakis S. (2007)
513. Psoriatic skin expresses the transcription factor Gli1: possible contribution of decreased neurofibromin expression. (PubMed id 16536802)⁹ Endo H....Shinkai H. (2006)
514. Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas. (PubMed id 17102089)⁹ Dahia P.L. (2006)
515. Molecular and cellular biology of pheochromocytomas and extra-adrenal paragangliomas. (PubMed id 17525480)⁹ Tischler A.S. (2006)
516. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma. (PubMed id 16149064)⁹ Langdon J.A....Clifford S.C. (2006)
517. Pediatric paraganglioma: an early manifestation of an adult disease secondary to germline mutations. (PubMed id 16304664)⁹ Mora J....Catala A. (2006)
518. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? (PubMed id 16735498)⁹ Jimenez C....Gagel R.F. (2006)
519. Characteristic genomic imbalances in pediatric pheochromocytoma. (PubMed id 16518846)⁹ Hering A....Loncarevic I. (2006)
520. PTPN11 gene analysis in 74 Brazilian patients with Noonan syndrome or Noonan-like phenotype. (PubMed id 17020470)⁹ Bertola D.R....Krieger J.E. (2006)
521. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene. (PubMed id 17103458)⁹ HA1ffmeier U....Rauch A. (2006)
522. A negative feedback signaling network underlies oncogene-induced senescence. (PubMed id 17157787)⁹ Courtois-Cox S....Cichowski K. (2006)
523. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations. (PubMed id 16467864)⁹ Niimi H....Kimura A. (2006)
524. Reduced growth of Drosophila neurofibromatosis 1 mutants reflects a non-cell-autonomous requirement for GTPase-Activating Protein activity in larval neurons. (PubMed id 17114577)⁹ Walker J.A....Bernards A. (2006)
525. 12-O-tetradecanoyl-phorbol-13-acetate-dependent up-regulation of dopaminergic gene expression requires Ras and neurofibromin in human IMR-32 neuroblastoma. (PubMed id 16635257)⁹ Mangoura D....Tsirimonaki E. (2006)
526. Tumours of familial origin in the head and neck. (PubMed id 16857415)⁹ Suarez C....Rinaldo A. (2006)
527. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. (PubMed id 16461335)⁹ Maertens O....Legius E. (2006)
528. Diffuse-type tenosynovial giant cell tumor in association with neurofibromatosis type 1-Noonan syndrome: possibly more than a chance relationship. (PubMed id 16723851)⁹ Posligua L....Dehner L.P. (2006)
529. Risk-oriented approach to hereditary adrenal pheochromocytoma. (PubMed id 17102110)⁹ Machens A....Dralle H. (2006)
530. Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA. (PubMed id 17087943)⁹ de Raedt T....Legius E. (2006)
531. Plasminogen activators and their inhibitor gene expression in cutaneous NF1-related neurofibromas. (PubMed id 16408192)⁹ SirAcn V....Vaheri A. (2006)
532. [Autosomal dominant mental retardation] (PubMed id 16506130)⁹ SA!nchez-DA-az A....Madrigal-Bajo I. (2006)
533. Stimulus-evoked release of neuropeptides is enhanced in sensory neurons from mice with a heterozygous mutation of the Nf1 gene. (PubMed id 16298082)⁹ Hingtgen C.M....Clapp D.W. (2006)
534. The mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma cell lines. (PubMed id 16239399)⁹ Mattingly R.R....Reiners J.J. (2006)
535. Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. (PubMed id 16787982)⁹ Bausch B....Neumann H.P. (2006)
536. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot? (PubMed id 16258955)⁹ Cascon A....Robledo M. (2006)
537. Cognitive dysfunction in NF1 knock-out mice may resul t from altered vesicular trafficking of APP/DRD3 complex. (PubMed id 16524466)⁹ Donarum E.A....Narayanan V. (2006)
538. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. (PubMed id 16267007)⁹ Dasgupta B....Gutmann D.H. (2005)
539. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. (PubMed id 15665300)⁹ Dasgupta B....Gutmann D.H. (2005)
540. Solitary subglottic neurofibroma: a report of an unusual manifestation. (PubMed id 15947937)⁹ GstAPttner M....Neher A. (2005)
541. FNAC diagnosis of MPNST--a case report. (PubMed id 16761762)⁹ Yadavrao K.A....Kanthirav K.G. (2005)
542. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. (PubMed id 16098468)⁹ Lee S....Schlisio S. (2005)
543. Schwann cell lines derived from malignant peripheral nerve sheath tumors respond abnormally to platelet-derived growth factor-BB. (PubMed id 15602756)⁹ Dang I. and DeVries G.H. (2005)
544. Repeated sequences in CASPASE-5 and FANCD2 but not NF1 are targets for mutation in microsatellite-unstable acute leukemia/myelodysplastic syndrome. (PubMed id 15886296)⁹ Offman J....Karran P. (2005)
545. Sensory neurons from Nf1 haploinsufficient mice exhibit increased excitability. (PubMed id 16093333)⁹ Wang Y....Hingtgen C.M. (2005)
546. The NF1 tumor suppressor critically regulates TSC2 and mTOR. (PubMed id 15937108)⁹ Johannessen C.M....Cichowski K. (2005)
547. Activating FLT3 mutations are rare in children with juvenile myelomonocytic leukemia. (PubMed id 15390271)⁹ Gratias E.J....Emanuel P.D. (2005)
548. A common pathway for genetic events leading to pheochromocytoma. (PubMed id 16098460)⁹ Maxwell P.H. (2005)
549. RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response. (PubMed id 15947106)⁹ Puxeddu E....Fagin J.A. (2005)
550. A mouse model for studying therapy-induced cancers. (PubMed id 16226702)⁹ Meadows A.T. (2005)
551. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. (PubMed id 15805275)⁹ Dasgupta B....Gutmann D.H. (2005)
552. Distinctive clinical presentation of a NF-1 patient with loss of heterozygosity of PTCH in his epithelial tumors. (PubMed id 16207184)⁹ Jacobson E....Smith K. (2005)
553. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas. (PubMed id 16001332)⁹ Bertherat J. and Gimenez-Roqueplo A.P. (2005)
554. Genomic organization and differential splicing of the mouse and human Pcyt2 genes. (PubMed id 14697519)⁹ Poloumienko A....Bakovic M. (2004)
555. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. (PubMed id 14644997)⁹ Loh M.L....Shannon K.M. (2004)
556. Causation of nervous system tumors in children: insights from traditional and genetically engineered animal models. (PubMed id 15313589)⁹ Rice J.M. (2004)
557. Cutaneous malignant melanoma and neurofibromatosis ty pe 1. (PubMed id 15057048)⁹ Guillot B....Wolkenstein P. (2004)
558. A novel role for mixed lineage kinase 3 (MLK3) in B-Raf activation and cell proliferation. (PubMed id 15467451)⁹ Chadee D.N. and Kyriakis J.M. (2004)
559. MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation. (PubMed id 15258589)⁹ Chadee D.N. and Kyriakis J.M. (2004)
560. The importance of genome architecture in cancer susceptibility: location, location, location. (PubMed id 15492507)⁹ Reilly K.M. (2004)
561. Hepatic nuclear factor 3 and nuclear factor 1 regulate 5-aminolevulinate synthase gene expression and are involved in insulin repression. (PubMed id 15123725)⁹ Scassa M.E....Canepa E.T. (2004)
562. Neurofibromatosis type 1 tumour suppressor gene expression is deficient in psoriatic skin in vivo and in vitro: a potential link to increased Ras activity. (PubMed id 14996090)⁹ Karvonen S.L....Peltonen J. (2004)
563. Familial segmental neurofibromatosis. (PubMed id 15224714)⁹ Oguzkan S....Aysun S. (2004)
564. Identification of NF1 as a silencer protein of the human adenine nucleotide translocase-2 gene. (PubMed id 15096217)⁹ Barath P....Nelson B.D. (2004)
565. Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases. (PubMed id 14743661)⁹ Kandt R.S. (2003)
566. Neurofibromatosis 1: a novel NF1 mutation in an 11-year-old girl with a giant cell granuloma. (PubMed id 12822827)⁹ Krammer U....Frisch H. (2003)
567. Cytogenetic characterization of three malignant peripheral nerve sheath tumors. (PubMed id 12810251)⁹ Frank D....FA1zesi L. (2003)
568. Structural fingerprints of the Ras-GTPase activating proteins neurofibromin and p120GAP. (PubMed id 12787671)⁹ Ahmadian M.R....Scheffzek K. (2003)
569. Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. (PubMed id 12881715)⁹ Gutmann D.H....Liskay R.M. (2003)
570. Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line. (PubMed id 12757776)⁹ Hube F.... Gruel Y. (2003)
571. Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells. (PubMed id 12393498)⁹ Ingram D.A....Clapp D.W. (2003)
572. [Cognitive impairment in adults with neurofibromatosis type 1] (PubMed id 12624853)⁹ Uttner I....Danek A. (2003)
573. Malignant blue nevus: a case report and molecular analysis. (PubMed id 12544095)⁹ Ariyanayagam-Baksh S.M....Barnes E.L. (2003)
574. The mechanism of Ras GTPase activation by neurofibromin. (PubMed id 12667087)⁹ Phillips R.A....Webb M.R. (2003)
575. Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis. (PubMed id 12612091)⁹ Miller S.J....Ratner N. (2003)
576. Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression. (PubMed id 12730955)⁹ Su W....Sherman L.S. (2003)
577. Bone development in neurofibromatosis 1. (PubMed id 12615500)⁹ Abdel-Wanis M.E. and Kawahara N. (2003)
578. NF1 mutations and molecular testing. (PubMed id 12403553)⁹ Thomson S.A....Wallace M.R. (2002)
579. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. (PubMed id 11788835)⁹ Tong J....Zhong Y. (2002)
580. Hyperactivation of protein kinase B and ERK have discrete effects on survival, proliferation, and cytokine expression in Nf1-deficient myeloid cells. (PubMed id 12498719)⁹ Donovan S....Shannon K.M. (2002)
581. Genetics of neurofibromatosis 1 and the NF1 gene. (PubMed id 12403554)⁹ Viskochil D. (2002)
582. The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter. (PubMed id 11895773)⁹ Peng Y. and Jahroudi N. (2002)
583. Aberrant G protein signaling in nervous system tumors. (PubMed id 12296648)⁹ Woods S.A....Guha A. (2002)
584. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease. (PubMed id 11904334)⁹ Kimura N....Kimura I. (2002)
585. Gene-targeted deletion of neurofibromin enhances the expression of a transient outward K+ current in Schwann cells: a protein kinase A-mediated mechanism. (PubMed id 12417644)⁹ Xu Y....Yamoah E.N. (2002)
586. Structural and functional characterization of the human PAX7 5'-flanking regulatory region. (PubMed id 12234688)⁹ Syagailo Y.V....Lesch K.P. (2002)
587. Losses in chromosomes 17, 19, and 22q in neurofibromatosis type 1 and sporadic neurofibromas: a comparative genomic hybridization analysis. (PubMed id 12237234)⁹ Koga T....Kikuchi M. (2002)
588. Neurofibromin in the brain. (PubMed id 12403558)⁹ Gutmann D.H. (2002)
589. Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases. (PubMed id 12616676)⁹ Kandt R.S. (2002)
590. Neurofibromatosis 1. (PubMed id 12432832)⁹ Lynch T.M. and Gutmann D.H. (2002)
591. Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors. (PubMed id 11406645)⁹ Birindelli S....Pilotti S. (2001)
592. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. (PubMed id 11404820)⁹ Astuti D.... Maher E.R. (2001)
593. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. (PubMed id 11294925)⁹ Li J....Gutmann D.H. (2001)
594. Members of the nuclear factor 1 family reduce the transcriptional potential of the nuclear receptor LXRalpha promoter. (PubMed id 11741331)⁹ Steffensen K.R....Eskild W. (2001)
595. Modeling myeloid leukemia tumor suppressor gene inactivation in the mouse. (PubMed id 11407944)⁹ Shannon K.M....Killeen N. (2001)
596. [Bilateral pheochromocytoma associated with duodeno-jejunal GIST in patient with von Recklinghausen disease: report of a clinical case] (PubMed id 11396074)⁹ Rizzo S....Rosa G. (2001)
597. Genetic aspects of pheochromocytoma. (PubMed id 11308996)⁹ Koch C.A....Pacak K. (2001)
598. Phosphorylation of neurofibromin by cAMP-dependent protein kinase is regulated via a cellular association of N(G),N(G)-dimethylarginine dimethylaminohydrolase. (PubMed id 11297733)⁹ Tokuo H....Araki N. (2001)
599. NF1 tumor suppressor gene function: narrowing the GAP . (PubMed id 11239415)⁹ Cichowski K. and Jacks T. (2001)
600. Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions. (PubMed id 11468690)⁹ Jenne D.E....Kehrer-Sawatzki H. (2001)
601. Aetiology of spinal deformities in neurofibromatosis 1: new hypotheses. (PubMed id 11359370)⁹ Abdel-Wanis M.E. and Kawahara N. (2001)
602. The arginine finger loop of yeast and human GAP is a determinant for the specificity toward Ras GTPase. (PubMed id 11412100)⁹ te Biesebeke R....Parmeggiani A. (2001)
603. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. (PubMed id 10767330)⁹ Rutkowski J.L....Legius E. (2000)
604. H-ras-1 point mutation in malignant peripheral nerve sheath tumors: polymerase chain reaction restriction fragment length polymorphism analysis and direct sequencing from paraffin-embedded tissues. (PubMed id 10812008)⁹ Watanabe T....Tsuneyoshi M. (2000)
605. Tumor antigen HuR binds specifically to one of five protein-binding segments in the 3'-untranslated region of the neurofibromin messenger RNA. (PubMed id 10673359)⁹ Haeussler J....Krone W. (2000)
606. Unequal meiotic crossover: a frequent cause of NF1 microdeletions. (PubMed id 10775528)⁹ Lopez Correa C....Legius E. (2000)
607. The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice. (PubMed id 10844550)⁹ Atit R.P....Ratner N. (2000)
608. Current topics in pheochromocytoma. (PubMed id 10915008)⁹ Nakao K....Takaya K. (2000)
609. A common set of at least 11 functional genes is lost in the majority of NF1 patients with gross deletions. (PubMed id 10843809)⁹ Jenne D.E.... Thiel G. (2000)
610. Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts. (PubMed id 10900196)⁹ Sherman L.S....Ratner N. (2000)
611. A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. (PubMed id 10706287)⁹ Guo H.F....Zhong Y. (2000)
612. [Characterization of the neurofibromatosis type 1 gene and neurofibromin's role in cells] (PubMed id 10921317)⁹ Sakai A. (2000)
613. Schwann cell-onion bulb tumor of the trigeminal nerve: hyperplasia, dysplasia or neoplasia? (PubMed id 10651030)⁹ LaPoint S.F....Sullivan R.P. (2000)
614. [A young woman with neurofibromatosis 1 (Recklinghausen disease), abdominal tumor and hypertension] (PubMed id 11129996)⁹ Schuppert F....von zur MA1hlen A. (2000)
615. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. (PubMed id 10754001)⁹ Yamauchi T....Fukui M. (2000)
616. New function for NF1 tumor suppressor. (PubMed id 10692105)⁹ Koivunen J....Peltonen J. (2000)
617. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. (PubMed id 10797293)⁹ Stephen A.L....Rose B.R. (2000)
618. Collision tumour in the pelvic cavity: rectal leiomyosarcoma and prostate adenocarcinoma. (PubMed id 10664249)⁹ Pavelic J....Pavelic K. (2000)
619. Penile neurofibromas. (PubMed id 10528238)⁹ Kousseff B.G. and Hoover D.L. (1999)
620. Characterization of Saccharomyces cerevisiae strains expressing ira1 mutant alleles modeled after disease-causing mutations in NF1. (PubMed id 10706001)⁹ Gil R. and Seeling J.M. (1999)
621. Sec14p-like domains in NF1 and Dbl-like proteins indicate lipid regulation of Ras and Rho signaling. (PubMed id 10209105)⁹ Aravind L....Ponting C.P. (1999)
622. Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor. (PubMed id 9878702)⁹ Rizvi T.A....Ratner N. (1999)
623. Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group. (PubMed id 10362810)⁹ Fletcher C.D....WillAcn H. (1999)
624. Absence of APOBEC-1 mediated mRNA editing in human carcinomas. (PubMed id 10597235)⁹ Greeve J....Greten H. (1999)
625. Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1. (PubMed id 10469340)⁹ Mashour G.A....Kurtz A. (1999)
626. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression. (PubMed id 10398103)⁹ Al-Mulla F....Birnie G.D. (1999)
627. Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer. (PubMed id 10023674)⁹ Dunn J....Field J.K. (1999)
628. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. (PubMed id 10469433)⁹ Woodruff J.M. (1999)
629. Magnesium fluoride-dependent binding of small G proteins to their GTPase-activating proteins. (PubMed id 10555980)⁹ Graham D.L....Lowe P.N. (1999)
630. [HNPCC syndrome, microsatellite instability and NF1 gene alteration] (PubMed id 10572231)⁹ Puisieux A. (1999)
631. Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway. (PubMed id 10029430)⁹ Feldkamp M.M....Guha A. (1999)
632. [Pathogenesis of malignant melanoma. Molecular biology aspect] (PubMed id 10427507)⁹ Waldmann V....NAoher H. (1999)
633. NF1 inactivation cooperates with N-ras in in vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity. (PubMed id 9796699)⁹ Mangues R....Pellicer A. (1998)
634. RXRA and HSPA5 map to the telomeric end of dog chromosome 9. (PubMed id 9720182)⁹ Werner P....Patterson D.F. (1998)
635. Ras activation in astrocytomas and neurofibromas. (PubMed id 9827227)⁹ Guha A. (1998)
636. The importance of two conserved arginine residues for catalysis by the ras GTPase-activating protein, neurofibromin. (PubMed id 9545275)⁹ Sermon B.A....Eccleston J.F. (1998)
637. Genetic variation in the 3' untranslated region of the neurofibromatosis 1 gene: application to unequal allelic expression. (PubMed id 9919310)⁹ Cowley G.S....Gusella J.F. (1998)
638. [A rare combination of pheochromocytoma ans somatostatin-rich neuroendocrine tumor of Vater's papilla (carcinoid) in a patient with von Recklinghausen neurofibromatosis] (PubMed id 9577907)⁹ Hardt P.D....Hinrichs B. (1998)
639. The human PTFgamma/SNAP43 gene: structure, chromosomal location, and identification of a VNTR in 5'-UTR. (PubMed id 9644240)⁹ Maeng J.H. and Yoon J.B. (1998)
640. Fluoride activation of the Rho family GTP-binding protein Cdc42Hs. (PubMed id 9468490)⁹ Hoffman G.R....Cerione R.A. (1998)
641. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia. (PubMed id 9783802)⁹ Garicochea B....Bendit I. (1998)
642. Ionic currents in normal and neurofibromatosis type 1-affected human Schwann cells: induction of tumor cell K current in normal Schwann cells by cyclic AMP. (PubMed id 9822160)⁹ Fieber L.A. (1998)
643. [Neurofibromatosis versus schwannomatosis] (PubMed id 9676422)⁹ Mautner V.F....Kluwe L. (1998)
644. A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein. (PubMed id 9742142)⁹ Ratner N....Brady S.T. (1998)
645. Secondary leukemias induced by topoisomerase-targeted drugs. (PubMed id 9748598)⁹ Felix C.A. (1998)
646. Identification of two novel mutations (1448delA and Q 682X) in the NF1 gene and analysis for nonsense mutations in patients with neur ofibromatosis type 1. (PubMed id 9452037)⁹ Horiuchi T....Fujita S. (1998)
647. Identification of conserved potentially regulatory sequences of the SRY gene from 10 different species of mammals. (PubMed id 9571157)⁹ Margarit E....Oliva R. (1998)
648. Fusion activity of transmembrane and cytoplasmic domain chimeras of the influenza virus glycoprotein hemagglutinin. (PubMed id 9420208)⁹ Schroth-Diez B....Herrmann A. (1998)
649. Loss of heterozygosity of NF1 gene in juvenile chronic myelogenous leukemia with neurofibromatosis type 1. (PubMed id 9713168)⁹ Kai S....Sasaki H. (1998)
650. Prolonged extreme thrombocytosis associated with neurofibromatosis type 1. (PubMed id 9042140)⁹ Hasle H....Tommerup N. (1997)
651. Four frameshift mutations in neurofibromatosis type 1 caused by small insertions. (PubMed id 9222967)⁹ Colman S.D....Wallace M.R. (1997)
652. Identification of cis-regulatory elements in the upstream regulatory region of human papillomavirus type 59. (PubMed id 9085547)⁹ Rho J....Choe J. (1997)
653. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase. (PubMed id 9001241)⁹ Kim H.A....Ratner N. (1997)
654. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome. (PubMed id 9209448)⁹ Misawa S....Kashima K. (1997)
655. [Molecular-genetic aspects of neurofibromatosis] (PubMed id 9190537)⁹ Hulsebos T.J. (1997)
656. Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma. (PubMed id 9169039)⁹ Martinsson T....Kogner P. (1997)
657. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas. (PubMed id 9100669)⁹ Huynh D.P....Pulst S.M. (1997)
658. Physical and linkage mapping of human chromosome 17 loci to dog chromosomes 9 and 5. (PubMed id 9177778)⁹ Werner P....Patterson D.F. (1997)
659. Skin abnormalities in neurofibromatosis 2. (PubMed id 9420538)⁹ Mautner V.F....Gottschalk J. (1997)
660. Chemotactic peptide-induced activation of Ras in human neutrophils is associated with inhibition of p120-GAP activity. (PubMed id 9287361)⁹ Zheng L....Andersson T. (1997)
661. [Evaluation of cancer risk through genetic analysis?] (PubMed id 9340835)⁹ Luz A. (1997)
662. Estrogen receptor diminishes DNA-binding activities of chicken GATA-1 and CACCC-binding proteins. (PubMed id 9428796)⁹ Holth L.T....Davie J.R. (1997)
663. Role of the NF1 gene in leukemogenesis and myeloid growth control. (PubMed id 9407945)⁹ O'Marcaigh A.S. and Shannon K.M. (1997)
664. The rat growth hormone and human cellular retinol binding protein 1 genes share homologous NF1-like binding sites that exert either positive or negative influences on gene expression in vitro. (PubMed id 9303437)⁹ Leclerc S....Guerin S.L. (1997)
665. Cloning and characterization of the human mitochondrial 3-hydroxy-3- methylglutaryl CoA synthase gene. (PubMed id 9305755)⁹ Boukaftane Y. and Mitchell G.A. (1997)
666. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras. (PubMed id 8668337)⁹ Gutmann D.H....Guha A. (1996)
667. Mechanism of inhibition by arachidonic acid of the catalytic activity of Ras GTPase-activating proteins. (PubMed id 8576154)⁹ Sermon B.A....Lowe P.N. (1996)
668. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. (PubMed id 8563751)⁹ Bollag G....Shannon K. (1996)
669. The translational placement of nucleosome cores in vitro determines the access of the transacting factor suGF1 to DNA. (PubMed id 8932393)⁹ Patterton H.G. and Hapgood J. (1996)
670. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. (PubMed id 8637706)⁹ Guha A....Boss G. (1996)
671. Isolation, mapping, and genomic structure of an X-linked gene for a subunit of human mitochondrial complex I. (PubMed id 8938439)⁹ Zhuchenko O.... Lee C.C. (1996)
672. Formation of a transition-state analog of the Ras GTPase reaction by Ras-GDP, tetrafluoroaluminate, and GTPase-activating proteins. (PubMed id 8658179)⁹ Mittal R....Wittinghofer A. (1996)
673. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. (PubMed id 8824721)⁹ Carbonara C....Migone N. (1996)
674. Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1: a pathological and molecular explanation. Case report. (PubMed id 8622163)⁹ Feldkamp M.M....Guha A. (1996)
675. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. (PubMed id 8563750)⁹ Largaespada D.A....Copeland N.G. (1996)
676. [Natural evolution of neurocutaneous syndrome in adul ts] (PubMed id 8755348)⁹ Pou Serradell A. (1996)
677. Expression of the neurofibromatosis 1 (NF1) gene during growth arrest. (PubMed id 8730839)⁹ Norton K.K....Gutmann D.H. (1996)
678. Induction of the HPV16 enhancer activity by Jun-B and c-Fos through cooperation of the promoter-proximal AP-1 site and the epithelial cell type--specific regulatory element in fibroblasts. (PubMed id 8938978)⁹ Kikuchi K....Yasumoto S. (1996)
679. Control of ras activation. (PubMed id 8909796)⁹ Downward J. (1996)
680. Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene. (PubMed id 7575561)⁹ BAPddrich A....NA1rnberg P. (1995)
681. Neurofibromin expression and astrogliosis in neurofib romatosis (type 1) brains. (PubMed id 7602332)⁹ Nordlund M.L....Ratner N. (1995)
682. Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region. (PubMed id 7734302)⁹ Leggett B....Ward M. (1995)
683. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype. (PubMed id 7627966)⁹ Yan N....Manne V. (1995)
684. Lack of NF1 expression in a sporadic schwannoma from a patient without neurofibromatosis. (PubMed id 8543966)⁹ Gutmann D.H....Rutkowski J.L. (1995)
685. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets. (PubMed id 7630628)⁹ Moodie S.A....Wolfman A. (1995)
686. Alterations of microsatellites in neurofibromas of von Recklinghausen's disease. (PubMed id 7585653)⁹ Ottini L....Calvieri S. (1995)
687. A conserved region of c-Ha-Ras is required for efficient GTPase stimulation by GTPase activating protein but not neurofibromin. (PubMed id 7499225)⁹ Yoder-Hill J....Stacey D.W. (1995)
688. Loss of neurofibromatosis type I (NF1) gene expression in pheochromocytomas from patients without NF1. (PubMed id 7542904)⁹ Gutmann D.H....Moley J.F. (1995)
689. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia. (PubMed id 8528106)⁹ Lee Y.Y....Choi I.Y. (1995)
690. Effect of retinoic acid on p21ras and regulators of its activity in neuroblastoma. (PubMed id 7576949)⁹ Burchill S.A....Lewis I.J. (1995)
691. Properties and regulation of the catalytic domain of Ira2p, a Saccharomyces cerevisiae GTPase-activating protein of Ras2p. (PubMed id 7577970)⁹ Parrini M.C....Parmeggiani A. (1995)
692. Identification and management of inherited cancer susceptibility. (PubMed id 8741802)⁹ Li F.P. (1995)
693. Interactions between Ras and Raf: key regulatory proteins in cellular transformation. (PubMed id 8607981)⁹ Marshall M. (1995)
694. Kinetics of inorganic phosphate release during the interaction of p21ras with the GTPase-activating proteins, p120-GAP and neurofibromin. (PubMed id 7492562)⁹ Nixon A.E....Webb M.R. (1995)
695. Neurofibromatosis type 1: pathology, clinical features and molecular genetics. (PubMed id 7670656)⁹ von Deimling A....Menon A.G. (1995)
696. Neurofibromatosis 1 gene (NF1) mutation is a rare genetic event in myelodysplastic syndrome regardless of the disease progression. (PubMed id 7599322)⁹ Kaneko H....Kashima K. (1995)
697. Regulation of the Ras signalling network. (PubMed id 7945277)⁹ Maruta H. and Burgess A.W. (1994)
698. Direct measurement of the binding of RAS to neurofibromin using a scintillation proximity assay. (PubMed id 7887472)⁹ Skinner R.H....Lowe P.N. (1994)
699. Genetic mechanisms of solid tumor oncogenesis. (PubMed id 8140969)⁹ Kelley M.J. and Johnson B.E. (1994)
700. Tumour predisposition in mice heterozygous for a targ eted mutation in Nf1. (PubMed id 7920653)⁹ Jacks T....Weinberg R.A. (1994)
701. Activation of the tyrosinase gene promoter by neurofibromin. (PubMed id 7811291)⁹ Suzuki H....Shibahara S. (1994)
702. Genetic basis of neurological tumours. (PubMed id 7952851)⁹ Louis D.N. and Seizinger B.R. (1994)
703. The NF1 gene in myelopoiesis and childhood myelodysplastic syndromes. (PubMed id 8302348)⁹ Brodeur G.M. (1994)
704. Study of 5'-flanking region of human Cu/Zn superoxide dismutase. (PubMed id 8024598)⁹ Kim H.T....Jung G. (1994)
705. TP53 mutations are frequent in malignant NF1 tumors. (PubMed id 7522538)⁹ Legius E....Glover T.W. (1994)
706. Species specificity and organ, cellular and subcellular localization of the 100 kDa Ras GTPase activating protein. (PubMed id 8006063)⁹ Mollat P....Thang M.N. (1994)
707. Identification of a human rasGAP-related protein containing calmodulin-binding motifs. (PubMed id 8051149)⁹ Weissbach L.... Bernards A. (1994)
708. A novel isoform of the neurofibromatosis type-1 mRNA and a switch of isoforms during murine cell differentiation and proliferation. (PubMed id 7958951)⁹ Mantani A....Yamamura K. (1994)
709. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. (PubMed id 7949098)⁹ Kalra R....Shannon K.M. (1994)
710. Binding of a member of the NF1 family of transcription factors to two distinct cis-acting elements in the promoter and 5'-flanking region of the human cellular retinol binding protein 1 gene. (PubMed id 7935489)⁹ Eskild W....Guerin S.L. (1994)
711. Absence of hereditary mutations in exons 5 through 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma. (PubMed id 8285583)⁹ van Meyel D.J....Cairncross J.G. (1994)
712. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation. (PubMed id 8108110)⁹ Rey I....Hall A. (1994)
713. Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. (PubMed id 8314000)⁹ Huynh D.P....Pulst S.M. (1994)
714. The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype. (PubMed id 7982912)⁹ Fridman M....Maruta H. (1994)
715. NF1 gene mutation and acute myelogenous leukaemia. (PubMed id 8142156)⁹ Horiuchi T....Fujita S. (1994)
716. Low frequency of NF1 gene mutations in malignant glio mas. (PubMed id 8518039)⁹ Tenan M....Finocchiaro G. (1993)
717. Human JC virus perfect palindromic nuclear factor 1-binding sequences important for glial cell-specific expression in differentiating embryonal carcinoma cells. (PubMed id 8380093)⁹ Kumar K.U....Pater M.M. (1993)
718. Cell transformation by ras and regulation of its protein product. (PubMed id 8299427)⁹ Lowy D.R....Look A.T. (1993)
719. [Functions of antioncogene products] (PubMed id 8346943)⁹ Akiyama T. (1993)
720. Plasma membrane-targeted ras GTPase-activating protein is a potent suppressor of p21ras function. (PubMed id 8455619)⁹ Huang D.C....Hancock J.F. (1993)
721. Autosomal dominant multiple cafAc-au-lait spots and ne urofibromatosis-1: evidence of non-linkage. (PubMed id 8456833)⁹ Charrow J....Ward K. (1993)
722. Interaction of GTPase activating proteins (GAPs) with p21ras measured by a novel fluorescence anisotropy method. Essential role of Arg-903 of GAP in activation of GTP hydrolysis on p21ras. (PubMed id 8496156)⁹ Brownbridge G.G....Webb M.R. (1993)
723. Role of GTPases and GTPase regulatory proteins in oncogenesis. (PubMed id 8353139)⁹ Grunicke H.H. and Maly K. (1993)
724. Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity. (PubMed id 8491185)⁹ Bollag G....Clark R. (1993)
725. Ring chromosome 22 and neurofibromatosis. (PubMed id 1424240)⁹ Tommerup N....Petersen G.B. (1992)
726. Interactions between p21ras proteins and their GTPase activating proteins. (PubMed id 1386285)⁹ Polakis P. and McCormick F. (1992)
727. [Magnetic resonance imaging of neurofibromatoses] (PubMed id 1300092)⁹ Raveau V....Tubiana J.M. (1992)
728. Mechanistic aspects of signaling through Ras in NIH 3T3 cells. (PubMed id 1496380)⁹ Zhang K....Lowy D.R. (1992)
729. The role of Gln61 and Glu63 of Ras GTPases in their activation by NF1 and Ras GAP. (PubMed id 1362901)⁹ Nur-E-Kamal M.S. and Maruta H. (1992)
730. Neurofibromatosis type 2 appears to be a genetically homogeneous disease. (PubMed id 1496982)⁹ Narod S.A....Haines J. (1992)
731. Beta-naphthoflavone induction of a cytochrome P-450 arachidonic acid epoxygenase in chick embryo liver distinct from the aryl hydrocarbon hydroxylase and from phenobarbital-induced arachidonate epoxygenase. (PubMed id 1527070)⁹ Nakai K....Rifkind A.B. (1992)
732. Transcriptional regulation by triiodothyronine requires synergistic action of the thyroid receptor with another trans-acting factor. (PubMed id 1324411)⁹ Voz M.L....Martial J.A. (1992)
733. Expression of neurofibromin, the neurofibromatosis 1 gene product: studies in human neuroblastoma cells and rat brain. (PubMed id 1436672)⁹ Huynh D.P....Pulst S.M. (1992)
734. The neurofibromatosis 1 gene transcripts expressed in peripheral nerve and neurofibromas bear the additional exon located in the GAP domain. (PubMed id 1280127)⁹ Teinturier C....Bernheim A. (1992)
735. Watson syndrome: is it a subtype of type 1 neurofibromatosis? (PubMed id 1770531)⁹ Allanson J.E....Harper P.S. (1991)
736. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. (PubMed id 1650459)⁹ Chapman B.S....Haigwood N.L. (1991)
737. Pathways of oncogenesis in primary brain tumors. (PubMed id 1909900)⁹ Steck P.A. and Saya H. (1991)
738. A genetic study of neurofibromatosis 1 in south-western Ontario. I. Population, familial segregation of phenotype, and molecular linkage. (PubMed id 1685193)⁹ Rodenhiser D.I....Singh S.M. (1991)
739. How does p21ras transform cells? (PubMed id 2031288)⁹ Marshall C.J. (1991)
740. Regulatory domains within the P0 promoter of human c-myc. (PubMed id 1945411)⁹ Lang J.C....Frame M.C. (1991)